Data / Research funding / Foodborne Illness
Foodborne Illness: 640 NIH awards ($705.6M) to 219 organizations
640 NIH awards ($705.6M) in the NIH spending category Foodborne Illness, to 219 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 640 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $44,959,734 | August 13, 2025 | November 30, 2026 | KOTLOFF, KAREN L. | reporter.nih.gov |
| The DUST Center: Hazardous Dust in Drylands - Exposure, Health Impacts, and Mitigation | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $11,160,526 | April 1, 1997 | January 31, 2030 | DING, XINXIN | reporter.nih.gov |
| Toxic substances in the environment | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $10,886,230 | April 1, 1997 | June 30, 2027 | SMITH, MARTYN T | reporter.nih.gov |
| Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,451,589 | September 17, 2021 | August 31, 2027 | FREEDMAN, STEPHEN BRADLEY | reporter.nih.gov |
| Human Biomimetics for Mucosal Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,059,968 | March 15, 2015 | May 31, 2027 | ESTES, MARY KOLB | reporter.nih.gov |
| Columbia University and Northern Plains Partnership for the Superfund Research Program | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $7,973,958 | September 21, 2022 | June 30, 2027 | NAVAS-ACIEN, ANA | reporter.nih.gov |
| Exploiting Diversity-Oriented Chemical Synthesis for Combating Chronic Parasitic Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,580,444 | February 8, 2020 | July 31, 2030 | SIBLEY, L. DAVID | reporter.nih.gov |
| Bacteriophage-based approach for managing Shigella infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,946,719 | May 5, 2020 | April 30, 2026 | SULAKVELIDZE, ALEXANDER | reporter.nih.gov |
| Coordinate Regulation of Virulence in Vibrio Cholerae | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,541,366 | July 1, 1981 | March 31, 2029 | MEKALANOS, JOHN JOSEPH | reporter.nih.gov |
| Structural Analysis and Inhibitor Optimization of Cryptosporidium n-myristoyltransferase for Drug Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,163,372 | November 15, 2020 | October 31, 2026 | STAKER, BART LEE | reporter.nih.gov |
| Leveraging novel mouse models to investigate toxic metal exposures on brain aging and Alzheimer's disease | NIH | National Institute on Aging | 2024 to 2025 | $4,141,255 | September 30, 2024 | August 31, 2029 | GOLDSTEIN, LEE E. | reporter.nih.gov |
| Optimization of Lead BKIs for Cryptosporidiosis Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,065,300 | January 1, 2021 | December 31, 2026 | VAN VOORHIS, WESLEY C | reporter.nih.gov |
| Cryo-EM of Helical Protein and Nucleoprotein Polymers at Near Atomic Resolution | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,949,496 | May 1, 2017 | April 30, 2027 | EGELMAN, EDWARD H. | reporter.nih.gov |
| Mechanisms of Prion Protein Toxicity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,903,115 | July 1, 2010 | June 30, 2026 | HARRIS, DAVID A | reporter.nih.gov |
| Mechanisms of protection against shigellosis in children | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,843,317 | June 9, 2022 | May 31, 2027 | PASETTI, MARCELA F | reporter.nih.gov |
| Functional profiling of OSP-specific and other antibodies during shigella infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,818,268 | September 22, 2020 | August 31, 2030 | RYAN, EDWARD T. | reporter.nih.gov |
| O-Specific Polysaccharide Responses and Cholera | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,758,033 | August 7, 2013 | March 31, 2030 | RYAN, EDWARD T. | reporter.nih.gov |
| Enteric Pathogen Force of Infection among Children using Serology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,719,600 | July 1, 2021 | June 30, 2027 | ARNOLD, BENJAMIN F | reporter.nih.gov |
| Host-pathogen interactions in experimental cholera | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,506,027 | January 1, 1998 | May 31, 2027 | WALDOR, MATTHEW K | reporter.nih.gov |
| Evaluation of Memory Responses and Biomarkers from a Phase IEnterotoxigenic Escherichia coli (ETEC) Intramuscular SubunitVaccine with dmLT Adjuvant | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,467,638 | September 24, 2021 | August 31, 2026 | NORTON, ELIZABETH B | reporter.nih.gov |
| Development of MecVax, a Cross Protective Subunit Vaccine for ETEC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,440,502 | June 1, 2023 | May 31, 2028 | ZHANG, WEIPING | reporter.nih.gov |
| Bumped-Kinase Inhibitor Drug Development for Toxoplasmosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,328,490 | March 15, 2021 | February 28, 2027 | VAN VOORHIS, WESLEY C | reporter.nih.gov |
| Diet transformation by the microbiome and its impact on bacterial infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,277,659 | August 16, 2022 | May 31, 2027 | GOODMAN, ANDREW L | reporter.nih.gov |
| Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,270,801 | March 15, 2021 | February 28, 2027 | KOSEK, MARGARET N | reporter.nih.gov |
| Advanced Development of a Combined Shigella-ETEC Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,267,570 | June 9, 2023 | May 31, 2028 | BARRY, EILEEN M. | reporter.nih.gov |
| The impact of non-dysentery Shigella-associated diarrhea in children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,197,662 | March 9, 2021 | February 28, 2027 | CHAKRABORTY, SUBHRA | reporter.nih.gov |
| Host Responses to the Pore-Forming Toxin Listeriolysin O | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,191,205 | April 1, 2021 | March 31, 2027 | SEVEAU, STEPHANIE M M | reporter.nih.gov |
| Vibrio cholerae antinitrosative stress defenses and gut microbiome interaction | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,145,639 | September 23, 2020 | August 31, 2025 | ZHU, JUN | reporter.nih.gov |
| The Impact of Drought on Arsenic Exposure and Cardiometabolic Outcomes in a Rural Aging Population | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,141,199 | August 5, 2021 | May 31, 2027 | JAMES, KATHERINE A | reporter.nih.gov |
| Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,134,727 | June 23, 2023 | May 31, 2028 | RYAN, EDWARD T. | reporter.nih.gov |
| Optimizing CDPK1 inhibitors for chronic toxoplasmosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,122,353 | March 1, 2022 | February 28, 2027 | SIBLEY, L. DAVID | reporter.nih.gov |
| Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,105,141 | June 1, 2015 | April 30, 2027 | GUNN, JOHN S | reporter.nih.gov |
| Anti-norovirus protease inhibitors for immunocompromised patients | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,063,131 | August 11, 2023 | July 31, 2027 | SCHINAZI, RAYMOND FELIX | reporter.nih.gov |
| Lactoferrin and lysozyme to promote nutritional, clinical, and enteric recovery: A factorial placebo-controlled randomized trial among children with diarrhea and malnutrition | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,033,175 | January 1, 2021 | November 30, 2025 | PAVLINAC, PATRICIA | reporter.nih.gov |
| Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,019,785 | June 1, 2021 | May 31, 2026 | KARST, STEPHANIE M | reporter.nih.gov |
| The Role of Type VI Secretion in Cholera Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,019,658 | January 18, 2019 | December 31, 2025 | PUKATZKI, STEFAN | reporter.nih.gov |
| Eco-evolutionary dynamics of Escherichia coli in an island system: Environmental drivers of waterborne urinary tract infections | NIH | Fogarty International Center | 2025 | $3,000,004 | September 9, 2025 | August 31, 2030 | STEWART, JILL RENE | reporter.nih.gov |
| Wells and Enteric Disease Transmission: A randomized trial of children supplied drinking water from private wells (WET-Trial) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,938,887 | September 1, 2020 | August 31, 2027 | MURPHY, HEATHER M | reporter.nih.gov |
| Arsenic and the Human Genome: susceptibility and response to exposure | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,925,364 | September 15, 2017 | July 31, 2025 | PIERCE, BRANDON LEE | reporter.nih.gov |
| Role of norovirus capsid dynamics in adaptive immune evasion | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,920,356 | September 1, 2025 | August 31, 2029 | SMITH, THOMAS JAMES. | reporter.nih.gov |
| Epidemiology and Ecology of Cholera in Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,910,980 | April 1, 2017 | February 29, 2028 | SACK, DAVID A | reporter.nih.gov |
| Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,904,818 | December 15, 2018 | January 31, 2025 | YEN, MINMIN | reporter.nih.gov |
| Role of CREM in Amebic Colitis and Inflammatory Bowel Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,896,698 | August 1, 1989 | December 31, 2027 | PETRI, WILLIAM A | reporter.nih.gov |
| Host Cell Signaling Pathways Induced by Salmonella | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,887,868 | May 1, 1995 | April 30, 2028 | GALAN, JORGE E | reporter.nih.gov |
| Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,855,157 | May 1, 2020 | April 30, 2026 | KELLER, MICHAEL DANIEL | reporter.nih.gov |
| Single dose azithromycin to prevent cholera in children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,854,798 | August 5, 2021 | May 31, 2027 | HARRIS, JASON B | reporter.nih.gov |
| Development of PTLS-209 for treatment for giardiasis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,849,878 | July 12, 2022 | June 30, 2027 | PADIA, JANAK K | reporter.nih.gov |
| Methionyl-tRNA Synthetase inhibitors can be developed as novel Giardiasis therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,821,765 | April 14, 2021 | March 31, 2026 | OJO, KAYODE K | reporter.nih.gov |
| Mycoestrogens and maternal-child health in the TIDES cohort | NIH | National Institute of Environmental Health Sciences | 2025 | $2,774,390 | September 11, 2025 | September 10, 2029 | RIVERA-NUNEZ, ZORIMAR | reporter.nih.gov |
| Preventing outbreaks of foodborne pathogenic bacteria in edible sprouts via novel resistance-conferring seed treatments | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,771,996 | April 1, 2020 | August 31, 2025 | DEJONGHE, WIM | reporter.nih.gov |
| The Impact of the Food Environment and Other Environmental Exposures on the Risk of Diabetes in Rural Settings | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,769,055 | July 1, 2020 | March 31, 2026 | LEE, DAVID C | reporter.nih.gov |
| Phage/Salmonella interactions during oxidative stress | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,727,148 | September 4, 2025 | August 31, 2029 | VAZQUEZ-TORRES, ANDRES | reporter.nih.gov |
| O-polysaccharide (OPS)-IpaB Conjugate Vaccine to Prevent Shigellosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,693,804 | June 1, 2023 | May 31, 2028 | PASETTI, MARCELA F | reporter.nih.gov |
| Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,681,067 | January 28, 2021 | December 31, 2026 | MONTEZ RATH, MARIA | reporter.nih.gov |
| Molecular Basis of Human Toxoplasmosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,672,900 | February 15, 2015 | February 28, 2026 | SIBLEY, L. DAVID | reporter.nih.gov |
| Role of Host Protein Kinase C in Cryptosporidiosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,669,401 | August 20, 2020 | July 31, 2025 | MARIE, CHELSEA S. | reporter.nih.gov |
| Broad spectrum Shigella subunit vaccine based on conserved proteins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,645,606 | February 4, 2021 | January 31, 2027 | PASETTI, MARCELA F | reporter.nih.gov |
| Quality Assessment Support | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,614,026 | April 1, 2015 | September 30, 2025 | BRECHER, STEVE | reporter.nih.gov |
| Sexual Development of Cryptosporidium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,590,871 | November 7, 2016 | May 31, 2027 | STRIEPEN, BORIS | reporter.nih.gov |
| Mechanisms of persistent Salmonella infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,581,090 | November 1, 2014 | October 31, 2025 | MONACK, DENISE M | reporter.nih.gov |
| The Pathogenesis of Enteric Fever | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,578,362 | February 24, 2021 | January 31, 2027 | FANG, FERRIC C | reporter.nih.gov |
| The role of tuft cells in norovirus pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,555,510 | July 8, 2020 | June 30, 2026 | WILEN, CRAIG BRIAN | reporter.nih.gov |
| A Ring Water, Sanitation, and Hygiene Intervention to Reduce Cholera in Hotspots in Bangladesh | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,538,009 | December 2, 2019 | November 30, 2026 | GEORGE, CHRISTINE MARIE | reporter.nih.gov |
| Role of ZBP1 in pathogenesis of Salmonella biofilms | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,527,208 | May 11, 2023 | April 30, 2028 | BALACHANDRAN, SIDDHARTH | reporter.nih.gov |
| The role of a bifunctional mucinase in modulating personalized gut microbiota-Vibrio cholerae interactions during infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,477,524 | June 1, 2023 | May 31, 2028 | ZHU, JUN | reporter.nih.gov |
| Novel Antigen Identification for an enterotoxigenic E coli vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,475,194 | July 1, 2010 | February 28, 2026 | FLECKENSTEIN, JAMES MICHAEL | reporter.nih.gov |
| The role of redox sensing in Listeria monocytogenes pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,460,153 | September 25, 2017 | July 31, 2027 | WOODWARD, JOSHUA | reporter.nih.gov |
| Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,441,424 | January 22, 2020 | December 31, 2025 | FENG, HANPING | reporter.nih.gov |
| Drinking Water Quality, the Health of Older Americans, and Inequality | NIH | National Institute on Aging | 2023 to 2025 | $2,440,931 | December 1, 2022 | November 30, 2027 | SHAPIRO, JOSEPH | reporter.nih.gov |
| Deciphering mechanisms of Listeria placental-fetal invasion | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,440,357 | June 15, 2022 | May 31, 2027 | FREITAG, NANCY ELIZABETH | reporter.nih.gov |
| Development of Robust and Low-cost Vaccines Against Salmonella Paratyphi A | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,427,378 | September 15, 2023 | August 31, 2028 | CANALS ALVAREZ, ROCIO | reporter.nih.gov |
| Protein Sialylation and De-Sialyation in Cell Surface Glycoprotein Homeostasis and Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,422,875 | February 1, 2021 | January 31, 2026 | MARTH, JAMEY | reporter.nih.gov |
| Woods Hole Center for Oceans and Human Health | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,398,691 | September 30, 2018 | February 28, 2029 | MCGILLICUDDY, DENNIS J | reporter.nih.gov |
| Phage Resistance in Emergent Vibrio cholerae and Phage Prophylaxis of Cholera | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,376,520 | May 15, 2003 | January 31, 2030 | CAMILLI, ANDREW | reporter.nih.gov |
| Gestational PFAS Mixture Exposures, Longitudinal Metabolomic Profiles, and Adolescent Cardiometabolic Health | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,367,874 | August 1, 2024 | July 31, 2025 | BRAUN, JOSEPH M | reporter.nih.gov |
| Quorum Sensing Regulation of EHEC Virulence Genes | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,346,135 | January 1, 2023 | December 31, 2027 | SPERANDIO, VANESSA | reporter.nih.gov |
| Development of a human intestinal microphysiological system for the study of immune responses to protozoan parasites | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,307,273 | July 5, 2023 | June 30, 2028 | KNOLL, LAURA J | reporter.nih.gov |
| Microbiota outgrowth by Salmonella | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,306,740 | May 1, 2011 | June 30, 2026 | BAUMLER, ANDREAS J | reporter.nih.gov |
| A cross protective multivalent vaccine for Shigella and ETEC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,277,877 | March 6, 2023 | February 29, 2028 | SACK, DAVID A | reporter.nih.gov |
| Serologic measures of enteric pathogen transmission for intervention studies and population monitoring in low-resource settings | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,275,772 | September 1, 2022 | August 31, 2028 | ARNOLD, BENJAMIN F | reporter.nih.gov |
| Tryptophan derivatives in EHEC pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,253,769 | August 8, 2022 | January 31, 2027 | SPERANDIO, VANESSA | reporter.nih.gov |
| Role of microglial phagocytosis in prion diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,251,988 | September 30, 2003 | February 28, 2029 | BASKAKOV, ILIA V | reporter.nih.gov |
| Initial clinical evaluation of attenuated Shigella flexneri 2a live vector expressing enterotoxigenic Escherichia coli antigens, strain CVD 1208S-122. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,244,622 | July 7, 2020 | April 30, 2025 | CHEN, WILBUR H. | reporter.nih.gov |
| Maximizing research success in studies of naturally-occurring prion diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,209,384 | May 15, 2023 | April 30, 2031 | TELLING, GLENN C | reporter.nih.gov |
| Randomized Control Trial of Nitazoxanide for the Treatment of Cryptosporidium Infection in Malnourished Children in Bangladesh | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,192,533 | May 1, 2025 | April 30, 2028 | KORPE, POONUM S. | reporter.nih.gov |
| Mechanisms and regulation of horizontal gene transfer by natural transformation in Vibrio cholerae | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,178,577 | September 1, 2018 | June 30, 2028 | DALIA, ANKUR | reporter.nih.gov |
| Developmental Exposures to Arsenic: Pneumonia, Immunity, and Microbiomes (DEAPIM) | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $2,157,462 | February 5, 2022 | December 31, 2026 | PARVEZ, MUHAMMAD F | reporter.nih.gov |
| How Substrate Dosage Drives Prion Disease Kinetics | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,150,963 | December 1, 2021 | November 30, 2026 | VALLABH, SONIA MINIKEL | reporter.nih.gov |
| Harnessing iron acquisition to hinder enterobacterial pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,144,328 | February 23, 2023 | January 31, 2028 | RAFFATELLU, MANUELA | reporter.nih.gov |
| Vibrio cholerae biofilms: structure, function, regulation and role in infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,137,055 | July 1, 2014 | May 31, 2026 | YILDIZ, HAVVA FITNAT | reporter.nih.gov |
| How Regulated Proteolysis Controls Bacterial Virulence | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,130,522 | February 1, 1992 | February 28, 2027 | GROISMAN, EDUARDO | reporter.nih.gov |
| Field Studies of Cryptosporidiosis in Bangladesh | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,127,460 | September 15, 1998 | March 31, 2029 | PETRI, WILLIAM A | reporter.nih.gov |
| Developing platforms for studying the impact of external stresses on multispecies biofilms. | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,111,205 | September 1, 2021 | June 30, 2026 | JONES, AKHENATON-ANDREW DHAFIR | reporter.nih.gov |
| Genetic Factors that Influence Arsenic Toxicity | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $2,098,902 | February 1, 2019 | January 31, 2025 | CHURCHILL, GARY A | reporter.nih.gov |
| Water Contaminants and Cardiovascular Risk: the Jackson Heart Study | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,087,529 | September 1, 2024 | July 31, 2028 | CARSON, APRIL P | reporter.nih.gov |
| Critical Lipid Species in the Hepatovirus Lifecycle | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,065,233 | December 12, 2019 | May 31, 2025 | LEMON, STANLEY M. | reporter.nih.gov |
| Humanized mouse models for arsenic toxicology | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,063,350 | August 17, 2021 | June 30, 2026 | STYBLO, MIROSLAV | reporter.nih.gov |
| Household Transmission of Cryptosporidium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,054,156 | July 1, 2019 | June 30, 2025 | KORPE, POONUM S. | reporter.nih.gov |
| Schistosomiasis at the edge of elimination: characterizing sources of new infections in residual transmission hotspots | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,041,847 | November 23, 2018 | October 31, 2025 | CARLTON, ELIZABETH | reporter.nih.gov |
| Public Drinking Water Contaminants and Infant Health: Advancing Environmental Justice | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $2,025,000 | September 14, 2021 | August 31, 2026 | NIGRA, ANNE E | reporter.nih.gov |
| Mucosal immunity to Toxoplasma gondii | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,023,454 | May 10, 2018 | June 30, 2029 | YAROVINSKY, FELIX | reporter.nih.gov |
| Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,018,372 | April 6, 2020 | January 31, 2026 | HUDSON, LAURIE G | reporter.nih.gov |
| Preclinical optimization of a parasiticidal drug for cryptosporidiosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,017,526 | March 1, 2019 | February 28, 2025 | HUSTON, CHRISTOPHER D | reporter.nih.gov |
| Impact of priming on the generation of intestinal tissue-resident memory T cells | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,017,466 | September 19, 2022 | July 31, 2027 | SHERIDAN, BRIAN S | reporter.nih.gov |
| Effect of Microbial Metabolites on Growth of Cryptosporidium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,012,133 | December 13, 2019 | November 30, 2024 | SIBLEY, L. DAVID | reporter.nih.gov |
| Rapid, Handheld, Point-of-Care Stool Sample-prep Device for the Extraction and Detection of Nucleic Acid from Diarrheal Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $2,010,626 | June 1, 2020 | May 31, 2025 | KIM, CHANG HEE | reporter.nih.gov |
| Novel cytoskeletal mechanisms of pathogenic bacteria interactions with intestinal epithelium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,007,027 | July 15, 2022 | April 30, 2027 | IVANOV, ANDREI IVANOVICH | reporter.nih.gov |
| ECHO Yakima Valley | NIH | Office of the Director, National Institutes of Health | 2025 | $2,004,977 | September 1, 2023 | May 31, 2030 | KARR, CATHERINE J | reporter.nih.gov |
| Dissecting Rotavirus Viroporin and Enterotoxin Calcium Signaling Pathways | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,000,000 | September 21, 2021 | August 31, 2027 | HYSER, JOSEPH M. | reporter.nih.gov |
| Enabling Toxoplasma gondii Kinome Directed Drug Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $2,000,000 | March 11, 2019 | November 30, 2025 | ZUTSHI, REENA | reporter.nih.gov |
| Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,996,911 | December 21, 2018 | November 30, 2024 | SONG, JEONGMIN | reporter.nih.gov |
| Role of Carbon Metabolism and Virulence of Shigella flexneri | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,976,709 | July 1, 2025 | June 30, 2030 | PAYNE, SHELLEY M. | reporter.nih.gov |
| Detection and Characterization of Blood-borne Prions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,975,477 | June 1, 2014 | May 31, 2026 | MATHIASON, CANDACE K. | reporter.nih.gov |
| Molecular mechanisms of Salmonella mediated autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,975,400 | June 1, 2020 | May 31, 2025 | TUKEL, CAGLA | reporter.nih.gov |
| Interferon-inducible cell-autonomous immunity to cytosolic bacterial pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,968,136 | September 1, 2019 | November 30, 2028 | COERS, JOERN | reporter.nih.gov |
| Genetic underpinning of diabetes associated with arsenic exposure | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,967,529 | February 1, 2019 | January 31, 2024 | PARDO-MANUEL DE VILLENA, FERNANDO | reporter.nih.gov |
| Listeria monocytogenes physiology and host pathogen interactions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,964,244 | February 1, 2015 | January 31, 2026 | WOODWARD, JOSHUA | reporter.nih.gov |
| RNA modifications by paternal exposure to arsenic and intergenerational effects on sperm quality | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $1,957,983 | April 29, 2022 | January 31, 2027 | HO, SHUK-MEI | reporter.nih.gov |
| Coordination of mucosal immune response to enteric bacterial pathogens by nociceptive innervation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,954,430 | April 1, 2020 | March 31, 2025 | REARDON, COLIN | reporter.nih.gov |
| Interspecies Bacterial Signaling to Regulate Salmonella Virulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,951,816 | May 24, 2021 | April 30, 2027 | ALTIER, CRAIG | reporter.nih.gov |
| Type III effector regulation of host signal transduction systems | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,943,726 | August 11, 2009 | May 31, 2026 | ALTO, NEAL MATHEW | reporter.nih.gov |
| Mechanisms of Salmonella-mediated disruption of colonization resistance in the inflamed gut | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,942,008 | September 19, 2022 | July 31, 2027 | BYNDLOSS, MARIANA XAVIER | reporter.nih.gov |
| Molecular signaling mechanisms controlling Cryptosporidium proliferation and development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,902,469 | February 1, 2021 | January 31, 2027 | ALAM, SUMITI VINAYAK | reporter.nih.gov |
| HUMAN GENETIC VARIATION REGULATING SALMONELLA HOST-PATHOGEN INTERACTIONS AND DISEASE SUSCEPTIBILITY | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,901,258 | August 1, 2015 | November 30, 2025 | KO, DENNIS CHUN-YONE | reporter.nih.gov |
| Mechanism of action of C. perfringens enterotoxin | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,895,697 | July 1, 1982 | March 31, 2026 | MC CLANE, BRUCE A | reporter.nih.gov |
| Mechanisms of host leukocyte-mediated Toxoplasma dissemination in its host | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,891,808 | May 17, 2022 | April 30, 2027 | SAEIJ, JEROEN | reporter.nih.gov |
| A Novel Engineered Probiotic for the Prevention of Clostridium Difficile Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,887,207 | July 1, 2020 | June 30, 2024 | FANGER, GARY | reporter.nih.gov |
| Mechanism for arsenic induced carcinogenesis | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,853,908 | August 1, 2017 | November 30, 2028 | STATES, J CHRISTOPHER | reporter.nih.gov |
| Role of reactive astrocytes in prion diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,848,959 | December 1, 2022 | November 30, 2027 | BASKAKOV, ILIA V | reporter.nih.gov |
| Virulence gene regulators of enteric bacterial pathogens: Determining the structural and functional mechanisms of small molecule and polypeptide inhibitors | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,844,071 | November 17, 2022 | October 31, 2027 | KULL, FREDRICK JON | reporter.nih.gov |
| Sugar regulation of EHEC virulance | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,835,355 | July 1, 2022 | June 30, 2026 | SPERANDIO, VANESSA | reporter.nih.gov |
| Molecular Pathogenesis of enterotoxigenic E. coli associated enteropathy | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,791,687 | January 15, 2023 | December 31, 2027 | FLECKENSTEIN, JAMES MICHAEL | reporter.nih.gov |
| Invasion of the enteric nervous system by neurotropic Listeria monocytogenes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,785,279 | July 1, 2023 | June 30, 2028 | D'ORAZIO, SARAH E. F. | reporter.nih.gov |
| Mechanisms of interaction between bacteriophage and their hosts throughout the infection cycle | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,763,654 | June 13, 2022 | May 31, 2027 | DOORE, SARAH M | reporter.nih.gov |
| Synthesis and quantitation of microcystins and anabaenopeptins in the Great Lakes region to establish human exposure risks via ingestion and inhalation | NIH | National Institute of Environmental Health Sciences | 2023 to 2024 | $1,749,173 | June 22, 2024 | August 31, 2026 | WESTRICK, JUDY A | reporter.nih.gov |
| Molecular determinants of Salmonella cell-envelope copper homeostasis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,747,882 | August 1, 2021 | July 31, 2025 | ARGUELLO, JOSE M | reporter.nih.gov |
| Field Instrument for Assessment of Arsenic Exposure | NIH | National Institute of Environmental Health Sciences | 2023 to 2024 | $1,744,224 | February 9, 2023 | January 31, 2026 | ARGUN, AVNI A | reporter.nih.gov |
| Typhoid Toxin and Salmonella Typhi pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,730,856 | September 16, 2014 | August 31, 2024 | GALAN, JORGE E | reporter.nih.gov |
| A Paper-Based Synthetic Biology Platform for the On-Demand Testing of Water Quality | NIH | National Institute of Environmental Health Sciences | 2022 to 2023 | $1,730,738 | September 20, 2022 | August 31, 2025 | ALAM, KHALID KAMAL | reporter.nih.gov |
| Molecular basis of intestinal cryptosporidiosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,720,474 | February 4, 2015 | February 28, 2027 | CHEN, XIAN-MING | reporter.nih.gov |
| The Function of Host-derived Extracellular Vesicles in Trafficking of Bacterial Antigens to Stimulate the Antibacterial Immune Response | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,718,880 | April 12, 2022 | March 31, 2028 | FERRARO, MARIOLA JADWIGA | reporter.nih.gov |
| Translation initiation factors driving persistence of Toxoplasma gondii bradyzoites in neurons | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,704,177 | December 8, 2022 | November 30, 2027 | SULLIVAN, WILLIAM J | reporter.nih.gov |
| Mechanoregulation of EHEC virulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,696,570 | May 2, 2018 | April 30, 2029 | KRACHLER, ANNE-MARIE | reporter.nih.gov |
| Role of inflammatory monocytes in immunity and host defense against Salmonella | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,667,262 | September 3, 2020 | August 31, 2025 | VAN DER VELDEN, ADRIANUS WILHELMUS MARIA | reporter.nih.gov |
| The impact of ER stress on Salmonella Typhimurium infections | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,664,730 | September 20, 2022 | July 31, 2027 | KEESTRA-GOUNDER, ARINA MARIJKE | reporter.nih.gov |
| High-throughput single-cell RNA sequencing of bacteria to uncover cell states involved in pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,646,044 | June 20, 2024 | April 30, 2029 | HORMOZ, SAHAND | reporter.nih.gov |
| Teaching Human Health and Water Stewardship using Extended Reality | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $1,626,457 | September 15, 2020 | June 14, 2023 | HENDRIX, JESSICA OCHOA | reporter.nih.gov |
| SBIR Direct Phase II: Nature Inspired Biphasic Glue for Dura Repair | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $1,614,207 | September 20, 2022 | August 31, 2025 | LIU, CHAO | reporter.nih.gov |
| Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,612,284 | November 25, 2018 | May 31, 2024 | KARST, STEPHANIE M | reporter.nih.gov |
| Characterization of a novel family of Small Regulatory Proteins modulating virulence in Enterobacteriaceae | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,602,460 | February 2, 2022 | January 31, 2027 | SANTIAGO, ARACELI ELVIRA | reporter.nih.gov |
| Environmental adaptation by Vibrio cholerae | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,594,929 | August 3, 2018 | February 29, 2028 | BINA, JAMES EDWARD | reporter.nih.gov |
| Development of a new marine natural product for the treatment of cryptosporidiosis, an AIDS-defining disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,575,153 | June 12, 2020 | May 31, 2026 | O'CONNOR, ROBERTA M | reporter.nih.gov |
| Shedding, retention and spreading of chronic wasting disease prions in the environment | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,550,709 | June 1, 2017 | August 31, 2030 | MORALES, RODRIGO | reporter.nih.gov |
| Microbial Metabolites Inhibiting Salmonella Carriage and Disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,535,339 | June 14, 2022 | May 31, 2027 | ALTIER, CRAIG | reporter.nih.gov |
| Salmonella Interactions with Macrophages | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,533,345 | July 3, 2024 | May 31, 2029 | MONACK, DENISE M | reporter.nih.gov |
| Filtration Media for In-Home PFAS Removal from Drinking Water | NIH | National Institute of Environmental Health Sciences | 2023 to 2024 | $1,526,266 | February 2, 2021 | July 31, 2025 | DIETZ, STEVEN D | reporter.nih.gov |
| Recurrence of Cholera in Haiti: Exploration of Contributing Factors and Intervention Strategies | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,523,958 | July 1, 2016 | March 31, 2029 | MORRIS, JOHN GLENN | reporter.nih.gov |
| Development of dual effective kinase inhibitors as syndromic treatment of Giardiasis and Cryptosporidiosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,515,650 | January 19, 2024 | November 30, 2028 | OJO, KAYODE K | reporter.nih.gov |
| Vibrio microcins. A hidden field of targeted anti-cholerae natural products. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,511,046 | June 1, 2024 | April 30, 2029 | DAVIES, BRYAN WILLIAM | reporter.nih.gov |
| Cyclin-mediated control of Toxoplasma development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,495,000 | May 8, 2020 | April 30, 2026 | SUVOROVA, ELENA | reporter.nih.gov |
| Implementation of ring strategy for community-engaged control of neurocysticercosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,490,754 | December 15, 2013 | December 31, 2024 | O'NEAL, SETH E | reporter.nih.gov |
| Antibody mediated protective immunity against cholera | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,483,473 | September 14, 2018 | August 31, 2024 | HARRIS, JASON B | reporter.nih.gov |
| Central metabolism of Salmonella in the inflamed gut | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,472,554 | May 1, 2015 | July 31, 2030 | WINTER, SEBASTIAN E | reporter.nih.gov |
| Targeted antibiotic therapy for Shigella among children in low-resource settings | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,466,767 | July 1, 2025 | June 30, 2029 | ROGAWSKI MCQUADE, ELIZABETH TACKET | reporter.nih.gov |
| Regulation of the physiology and function of the digestive vacuole in Toxoplasma gondii | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,465,954 | December 10, 2019 | November 30, 2025 | DOU, ZHICHENG | reporter.nih.gov |
| Host factors in shigellosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,464,310 | December 1, 2023 | October 31, 2028 | AGAISSE, HERVE F | reporter.nih.gov |
| Epidemiology and impact of diverse Campylobacter species in low-resource settings | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,462,426 | June 1, 2020 | May 31, 2026 | PLATTS-MILLS, JAMES ALEXANDER | reporter.nih.gov |
| Small molecule inhibitors targeting the ribosome binding site of ricin and Shiga toxin | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,437,573 | March 1, 2024 | January 31, 2029 | TUMER, NILGUN E | reporter.nih.gov |
| Vaccine- and infection-derived correlates of protection for cholera | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,430,832 | June 1, 2025 | May 31, 2029 | HARRIS, JASON B | reporter.nih.gov |
| Multi-component chlorination intervention to reduce neonatal infections in rural health facilities | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,429,189 | June 7, 2024 | April 30, 2029 | PICKERING, AMY J. | reporter.nih.gov |
| RNA-binding proteins in bacterial virulence and host-pathogen interactions | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,426,728 | January 14, 2023 | December 31, 2027 | KENDALL, MELISSA | reporter.nih.gov |
| Environmental Metal Toxicity and Kidney Tubule Measures in Diverse Populations | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,418,959 | March 1, 2024 | February 28, 2028 | SHLIPAK, MICHAEL G | reporter.nih.gov |
| Identification and Characterization of Genes Required for Listeria monocytogenes Cytosolic Survival | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,418,713 | June 12, 2024 | April 30, 2029 | SAUER, JOHN-DEMIAN | reporter.nih.gov |
| Understanding Innate Immune Recognition and IFN-g-Mediated Immunity in Cryptosporidiosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,415,564 | May 21, 2024 | March 31, 2029 | YAROVINSKY, FELIX | reporter.nih.gov |
| Microbial ecology of the inflamed intestine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,411,946 | September 24, 2018 | August 31, 2024 | AHMER, BRIAN M | reporter.nih.gov |
| Development of a Portable Ion Mobility Spectrometer For Efficient Diagnosis of Various Diseases | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,406,784 | September 22, 2022 | July 31, 2027 | HAMID, AHMED MOHAMED | reporter.nih.gov |
| Immune-based therapy against STEC intoxication and HUS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,403,077 | November 19, 2020 | October 31, 2025 | TZIPORI, SAUL R | reporter.nih.gov |
| SBIR Phase II: Evaluating the feasibility of the TotalTHM-NOW for drinking water treatment plants to improve water quality, reduce costs, and lower cancer risks | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,397,618 | September 5, 2019 | May 31, 2024 | BRISTER, PAUL CLIFTON | reporter.nih.gov |
| Urban Water Systems, Enteric Pathogen Distribution & Gut Microbiome Development in Children: A Natural Experiment in Mozambique | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,392,100 | January 16, 2018 | December 31, 2024 | FREEMAN, MATTHEW C | reporter.nih.gov |
| Drinking water salinity in a hot-dry environment: Hydration, kidney function, and blood pressure | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,387,992 | September 20, 2024 | June 30, 2029 | ROSINGER, ASHER Y. | reporter.nih.gov |
| Aflatoxin Exposure, Growth Faltering, and the Gut Microbiome among Children in Rural Guatemala | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,382,014 | January 1, 2023 | October 31, 2027 | KRAJMALNIK-BROWN, ROSA | reporter.nih.gov |
| Impact of Maternal Arsenic Exposure on Offspring's Epigenetic Reprogramming of Allergic Airway Disease | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,381,185 | August 2, 2023 | May 31, 2028 | TANG, WAN-YEE | reporter.nih.gov |
| Nutritional immunity during Salmonella infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,378,574 | May 15, 2016 | July 31, 2028 | RAFFATELLU, MANUELA | reporter.nih.gov |
| Commercialization of Novel Silicon Microslit Filters for Microplastic Contamination Testing | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,371,081 | September 1, 2019 | July 31, 2024 | ROUSSIE, JAMES ANDREW | reporter.nih.gov |
| Capturing the genomic variation present in Cryptosporidium and cryptosporidiosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,368,598 | August 20, 2020 | July 31, 2025 | KISSINGER, JESSICA C | reporter.nih.gov |
| How Vitamin D Receptor Influences Intestinal Barriers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,357,761 | April 1, 2018 | February 29, 2028 | SUN, JUN | reporter.nih.gov |
| Structural insight into novel mechanisms of type III secretion | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,346,250 | December 1, 2011 | April 30, 2025 | KALODIMOS, CHARALAMPOS | reporter.nih.gov |
| Repurposing the EMD-Serono "mini-library" for Cryptosporidium drug development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,343,491 | February 8, 2019 | January 31, 2025 | HUSTON, CHRISTOPHER D | reporter.nih.gov |
| Estimating Cholera Burden with Cross-sectional Immunologic Data | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,310,561 | May 25, 2018 | October 31, 2023 | LEUNG, DANIEL TED | reporter.nih.gov |
| Pharmacokinetic and pharmacodynamic relationships for antibacterial treatment of shigellosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,308,927 | April 6, 2023 | March 31, 2028 | ARNOLD, SAMUEL L | reporter.nih.gov |
| Ultra-processed food reward: neural and metabolic factors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,285,062 | February 1, 2023 | January 31, 2028 | DIFELICEANTONIO, ALEXANDRA GOLD | reporter.nih.gov |
| Intestinal uptake, translocation, biodistribution, and toxicity of ingested environmentally relevant micro-nanoplastics (MNPs) and the role of inflammation using advanced cellular and in vivo models | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,276,583 | July 15, 2024 | June 30, 2029 | DEMOKRITOU, PHILIP | reporter.nih.gov |
| Host cell membrane perforation during invasion by Toxoplasma gondii | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,265,556 | January 3, 2023 | December 31, 2027 | WARD, GARY E | reporter.nih.gov |
| Norovirus regulation via bacterial modulation of interferon-lambda | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,252,136 | March 1, 2019 | February 29, 2024 | BALDRIDGE, MEGAN T | reporter.nih.gov |
| Developmental Exposures to Arsenic: Pneumonia, Immunity, and Microbiomes (DEAPIM) | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,248,392 | March 10, 2021 | July 31, 2022 | PARVEZ, MUHAMMAD F | reporter.nih.gov |
| Target Antigen Identification to Generate a Cross-serovar Salmonella Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,244,483 | June 1, 2018 | March 31, 2030 | MCSORLEY, STEPHEN J | reporter.nih.gov |
| Leveraging Investments in the Seychelles Child Development Study to Enable Novel Investigations of Long-Term MeHg Exposure, Toxicity Mechanisms, and Health across the Life Course | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $1,231,286 | March 16, 2020 | December 31, 2025 | VAN WIJNGAARDEN, EDWIN | reporter.nih.gov |
| Accelerating Data and Metadata Standards in the Environmental Health Sciences Study of Emerging Water Contaminants | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,226,335 | May 15, 2024 | February 28, 2029 | CHEUNG, KEI-HOI | reporter.nih.gov |
| Pediatric toxoplasmosis: Addressing unmet medical need with 3D printed dose flexible delivery systems of pyrimethamine, sulphadiazine and leucovorin | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,219,176 | September 11, 2024 | May 31, 2029 | KHAN, MANSOOR A | reporter.nih.gov |
| Interdisciplinary approaches for understanding the metabolic effects of arsenic and manganese | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,216,903 | September 15, 2020 | August 31, 2025 | GAMBLE, MARY | reporter.nih.gov |
| Metabolic basis for the persistence of dormant Toxoplasma gondii infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,214,783 | November 23, 2022 | October 31, 2027 | BZIK, DAVID J | reporter.nih.gov |
| Quantitative Systemic Studies of Bacterial Physiology | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $1,210,034 | March 1, 2024 | February 28, 2029 | HWA, TERENCE | reporter.nih.gov |
| Emerging novel mechanisms of antibiotic resistance in the prevalent foodborne pathogen, Salmonella | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,182,750 | September 23, 2019 | August 31, 2025 | BHATT, AMI SIDDHARTH | reporter.nih.gov |
| Arsenic, the Microbiome & Health Outcomes: Mechanisms to Methods of Intervention | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,175,395 | December 7, 2022 | October 31, 2027 | O'TOOLE, GEORGE A. | reporter.nih.gov |
| Cadmium and Arsenic Effects on Pyrimidine Biosynthesis in Early Airway Development | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,173,750 | March 5, 2023 | February 28, 2027 | HU, XIN | reporter.nih.gov |
| Role of skin prions in disease transmission and diagnostic testing of human prion disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,171,964 | September 15, 2018 | June 30, 2024 | KONG, QINGZHONG | reporter.nih.gov |
| The impact of shigellosis and recommended treatment in children | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,167,741 | September 2, 2025 | August 31, 2030 | CHAKRABORTY, SUBHRA | reporter.nih.gov |
| Development of Smart Flocculants for the Treatment of PFAS Contaminated Water | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,158,962 | September 10, 2020 | April 30, 2026 | ROWLANDS, CLAIRE E | reporter.nih.gov |
| Automated, in-line hexavalent chromium analyzer | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,153,835 | September 3, 2024 | August 31, 2026 | PETERMAN, MARK C | reporter.nih.gov |
| PFAS sensor for remediation and industrial wastewater treatment optimization applications | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,152,091 | June 21, 2022 | August 31, 2027 | ROODENKO, ECATHERINA | reporter.nih.gov |
| Salmonella-specific Th1 cell function and residence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,149,920 | January 10, 2019 | December 31, 2024 | MCSORLEY, STEPHEN J | reporter.nih.gov |
| Identification and Characterization of Genes Required for Listeria monocytogenes Cytosolic Survival | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,147,317 | September 24, 2018 | August 31, 2024 | SAUER, JOHN-DEMIAN | reporter.nih.gov |
| Effects of host endocannabinoid signaling on Enterobacteriaceae infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,140,243 | June 6, 2024 | April 30, 2029 | ELLERMANN, MELISSA | reporter.nih.gov |
| Intensified, High-Rate Reductive Immobilization of Hexavalent Chromium | NIH | National Institute of Environmental Health Sciences | 2022 to 2023 | $1,138,687 | September 20, 2022 | August 31, 2025 | SHIRAZI, FATEMEH | reporter.nih.gov |
| Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning. | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,132,082 | April 15, 2011 | June 30, 2022 | ICHTCHENKO, KONSTANTIN | reporter.nih.gov |
| Identification of Regulatory Loci of Stx2a Cytotoxin Production in Shiga toxin producing Escherichia coli (STEC) | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,125,000 | May 1, 2020 | April 30, 2025 | EPPINGER, MARK | reporter.nih.gov |
| Vaccines to counter emerging antibiotic resistance | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,121,304 | May 1, 2018 | April 30, 2023 | PICKING, WENDY L. | reporter.nih.gov |
| Determinants of Enteric Calicivirus Infection. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,119,642 | July 1, 2019 | June 30, 2026 | FARKAS, TIBOR | reporter.nih.gov |
| The role of structural plasticity in the norovirus capsid | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,118,674 | February 1, 2019 | January 31, 2025 | SMITH, THOMAS JAMES. | reporter.nih.gov |
| Host-cell mitochondrial alterations play a central role in EPEC pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,103,794 | June 7, 2019 | May 31, 2025 | VISWANATHAN, V K | reporter.nih.gov |
| Characterization of a commensal enteric virus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,102,694 | September 20, 2011 | August 31, 2023 | CADWELL, KEN HASHIGIWA | reporter.nih.gov |
| Cracking Salmonella Typhis Secret Code: Understanding Pathogenic Mechanisms of Salmonella Typhi Toxin | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,077,168 | June 4, 2018 | May 31, 2024 | SONG, JEONGMIN | reporter.nih.gov |
| Detection of asymptomatic Salmonella enterica serotype Typhi and Paratyphi A carriage by serum antibodies targeting YncE | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,072,824 | August 15, 2018 | July 31, 2024 | CHARLES, RICHELLE C | reporter.nih.gov |
| Assessing measures to eliminate transmission of cholera in Haiti | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $1,072,308 | September 27, 2012 | June 30, 2025 | HARRIS, JASON B | reporter.nih.gov |
| Mechanisms of arsenic detoxification by the human microbiome | NIH | National Cancer Institute | 2021 to 2025 | $1,068,729 | August 1, 2017 | March 31, 2029 | WALK, SETH T | reporter.nih.gov |
| Inter-kingdom interactions of Salmonella Typhimurium and Candida albicans in the gut | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,053,092 | November 9, 2023 | October 31, 2028 | BEHNSEN, JUDITH | reporter.nih.gov |
| The role of PFAS in lipid-mediated vascular contributions to cognitive impairment and dementia: PFAS VascCog Longitudinal Study | NIH | National Institute on Aging | 2024 to 2025 | $1,032,220 | May 15, 2024 | January 31, 2029 | GARDENER, HANNAH | reporter.nih.gov |
| Assay development and screening for inhibitors targeting Shiga toxin 2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,031,236 | January 25, 2019 | December 31, 2024 | LI, XIAO-PING | reporter.nih.gov |
| Biology, Bioinformatics & Chemistry Academy for Research Scholars (B2-CARS): A Partnership to Address Human Health Through Waste Water Remediation | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,027,927 | September 11, 2020 | July 31, 2025 | MILLIGAN, KIMBERLY ANNE | reporter.nih.gov |
| Assessment of pediatric immunotoxicity, public education, and capacity-building in communities impacted by PFAS-contaminated drinking water | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,027,388 | September 7, 2018 | June 30, 2025 | SCHAIDER, LAUREL A. | reporter.nih.gov |
| Mechanisms of Altered Gastrointestinal Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,026,000 | September 15, 2013 | April 30, 2026 | VERNE, GEORGE NICHOLAS | reporter.nih.gov |
| Dissecting innate immune control of intestinal and systemic Yersinia infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,024,897 | March 3, 2025 | February 28, 2030 | BRODSKY, IGOR E | reporter.nih.gov |
| Fluorescence-solid phase Extraction (F-SPE) Microfluidic Platform for Rapid, Onsite Detection and Identification of PFAS with Machine Learning | NIH | National Institute of Environmental Health Sciences | 2025 | $1,020,000 | May 16, 2023 | May 31, 2027 | BECK, JASON GREGORY | reporter.nih.gov |
| Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,000,000 | December 16, 2024 | May 31, 2027 | YEN, MINMIN | reporter.nih.gov |
| Hepatoselective Dihydrozuinolizone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,000,000 | April 10, 2023 | July 31, 2027 | DU, YANMING | reporter.nih.gov |
| A Two-Tier Effect-Based Water Bioactivity Surveillance System. | NIH | National Institute of Environmental Health Sciences | 2025 | $999,999 | August 8, 2025 | July 31, 2027 | MAKAROV, SERGEI S | reporter.nih.gov |
| The Role of Enteric Infection in Flares of Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $997,800 | January 15, 2021 | February 28, 2026 | AXELRAD, JORDAN ERIC | reporter.nih.gov |
| Virulence Factors of Salmonella | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $991,078 | June 15, 1999 | March 31, 2024 | BAUMLER, ANDREAS J | reporter.nih.gov |
| Genetic Analysis of Cryptosporidium | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $974,017 | May 15, 2014 | April 30, 2029 | STRIEPEN, BORIS | reporter.nih.gov |
| T-bet-regulated myeloid innate defense against Toxoplasma gondii | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $945,000 | July 1, 2023 | June 30, 2028 | LOPEZ-YGLESIAS, AMERICO HARRY | reporter.nih.gov |
| Effectiveness and scalability of a home health navigator program to reduce environmental hazards | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $930,702 | September 10, 2020 | June 30, 2025 | KILE, MOLLY L | reporter.nih.gov |
| Gut microbiome communication with the bone marrow regulates intestinal inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $918,980 | March 16, 2020 | June 4, 2024 | BURGESS, STACEY L | reporter.nih.gov |
| Central metabolism of Salmonella in the inflamed gut | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $904,111 | February 24, 2021 | June 30, 2022 | WINTER, SEBASTIAN E | reporter.nih.gov |
| Understanding protection against norovirus at the maternal-child interface | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $901,443 | December 6, 2018 | January 31, 2029 | BECKER-DREPS, SYLVIA IRENE | reporter.nih.gov |
| Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $900,000 | July 16, 2019 | June 30, 2025 | HUANG, XUEFEI | reporter.nih.gov |
| Developmental windows for arsenic-associated diabetes | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $897,943 | September 1, 2018 | May 31, 2024 | STYBLO, MIROSLAV | reporter.nih.gov |
| Integrating data streams with multi-scale modeling to guide norovirus vaccine decision-making | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $853,759 | June 1, 2018 | May 31, 2024 | LOPMAN, BENJAMIN A | reporter.nih.gov |
| Expanding Safe Water Access to Improve Health Outcomes in Appalachia: The Rural Water Filtration and Health (RWELL) Trial | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $832,818 | August 1, 2025 | July 31, 2030 | COHEN, ALASDAIR | reporter.nih.gov |
| Impact of Toxic Metal Exposures in Novel Genetic Mouse Models of Late-Onset Alzheimer's Disease | NIH | National Institute on Aging | 2023 | $822,643 | September 15, 2023 | August 31, 2025 | GOLDSTEIN, LEE E. | reporter.nih.gov |
| Systemic and gastrointestinal targeted CDPK1 inhibitors for cryptosporidiosis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $812,603 | June 9, 2025 | May 31, 2030 | CUNY, GREGORY D | reporter.nih.gov |
| Discovery of Hsp100-selective inhibitors for targeting multiple microbial pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $807,855 | July 1, 2019 | June 30, 2025 | ZOLKIEWSKI, MICHAL | reporter.nih.gov |
| Promoting scientific communication and intergenerational learning in a K-12 drinking water project (Communicating Data) | NIH | National Institute of Nursing Research | 2023 to 2025 | $805,009 | June 20, 2023 | May 31, 2028 | DISNEY, JANE ELIZABETH | reporter.nih.gov |
| Bacterial modulation of noncanonical inflammasome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $797,500 | January 16, 2018 | September 7, 2023 | KAILASAN VANAJA, SIVAPRIYA | reporter.nih.gov |
| Development of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $792,965 | December 1, 2021 | November 30, 2023 | MINIKEL, ERIC VALLABH | reporter.nih.gov |
| Gut complement system: Induction and protection against enteric infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $790,356 | January 24, 2025 | December 31, 2029 | KASPER, DENNIS L. | reporter.nih.gov |
| Mechanisms of Diet-Induced Pathogen Expansion in the Gut | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $785,744 | June 1, 2018 | May 31, 2023 | MONACK, DENISE M | reporter.nih.gov |
| Arsenic and other co-metals in the San Carlos Apache drinking water | NIH | National Cancer Institute | 2021 to 2025 | $785,110 | September 1, 2021 | August 31, 2026 | SAMUEL-NAKAMURA, CHRISTINE | reporter.nih.gov |
| Typhoid Vaccines Targeting Both Salmonella Typhi and Its Secreted Virulence Factor | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $785,000 | June 8, 2018 | May 31, 2024 | SONG, JEONGMIN | reporter.nih.gov |
| Human B cell responses to a live attenuated cholera vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $780,000 | July 1, 2018 | June 30, 2025 | WRAMMERT, JENS PETER | reporter.nih.gov |
| Integration of nutrient availability, TCA cycle activity, and colonization factor expression in Campylobacter jejuni | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $777,500 | July 6, 2022 | June 30, 2027 | JOHNSON, JEREMIAH | reporter.nih.gov |
| Role of Immunity and the Microbiota in Enteropathogenic E. coli Eradication | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $773,052 | May 20, 2013 | December 31, 2023 | NUNEZ, GABRIEL | reporter.nih.gov |
| Tryptophan derivatives in EHEC pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $770,263 | February 1, 2021 | August 7, 2022 | SPERANDIO, VANESSA | reporter.nih.gov |
| Prefrontal amygdala interactions in fear conditioning | NIH | National Institute of Mental Health | 2021 to 2022 | $750,000 | August 1, 2018 | April 30, 2024 | BRAVO-RIVERA, CHRISTIAN EMMANUELL | reporter.nih.gov |
| Arsenic related cystic fibrosis | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $749,691 | February 1, 2018 | January 31, 2024 | MAZUMDAR, MAITREYI | reporter.nih.gov |
| Biological vector borne transmission of Salmonella by cockroaches | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $749,279 | November 1, 2022 | November 2, 2024 | PIETRI, JOSE ENRIQUE | reporter.nih.gov |
| Evaluating the effect of water fluoridation on adverse birth outcomes | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $747,000 | September 1, 2023 | August 31, 2027 | GOIN, DANA E | reporter.nih.gov |
| Harnessing PET to Study the In Vivo Fate and Health Effects of Micro- and Nanoplastics | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $747,000 | September 15, 2023 | August 31, 2026 | KEINAENEN, OUTI MARIA | reporter.nih.gov |
| MicroRNAs, ER Stress and Arsenic Neurotoxicity | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $746,994 | February 5, 2021 | January 31, 2025 | PARK, HAE-RYUNG | reporter.nih.gov |
| The role of gut microbiota in human norovirus infections in transplant patients | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $742,196 | June 22, 2022 | May 31, 2027 | CHONG, PEARLIE PAO EE | reporter.nih.gov |
| Integration of nutrient availability, TCA cycle activity, and colonization factor expression in Campylobacter jejuni | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $739,955 | July 6, 2022 | July 31, 2024 | JOHNSON, JEREMIAH | reporter.nih.gov |
| Development of edible sorbent therapies to mitigate dietary exposures to per- and polyfluoroalkyl substances (PFAS) | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $729,680 | September 1, 2024 | August 31, 2027 | WANG, MEICHEN | reporter.nih.gov |
| Salmonella type III secretion: substrate targeting and injectisome assembly | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $728,244 | August 2, 2024 | July 31, 2025 | HUGHES, KELLY T | reporter.nih.gov |
| Antimicrobial resistant E. coli before and after California Senate bill 27 (ARES): a natural experiment | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $716,971 | May 9, 2017 | April 30, 2023 | TARTOF, SARA | reporter.nih.gov |
| Influence of microbial metabolites on mitosome function in Cryptosporidium | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $715,894 | August 8, 2025 | July 31, 2030 | SIBLEY, L. DAVID | reporter.nih.gov |
| Multimodal behavioral analysis of oromanual food-handling in freely moving animals | NIH | National Institute on Drug Abuse | 2024 to 2025 | $713,552 | February 1, 2024 | January 31, 2026 | SHEPHERD, GORDON M | reporter.nih.gov |
| Cholera persistence, transmission, and clinical illness in Haiti | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $712,682 | December 2, 2016 | November 30, 2023 | MORRIS, JOHN GLENN | reporter.nih.gov |
| Environmental Arsenic in the Subtype Specification of Breast Cancer | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $710,620 | June 30, 2020 | August 31, 2024 | BONINI, MARCELO G. | reporter.nih.gov |
| Role of CD300 Family in Norovirus Tropism, Persistence, and Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $699,874 | May 22, 2017 | April 30, 2023 | BALDRIDGE, MEGAN T | reporter.nih.gov |
| Gut microbiome communication with the bone marrow regulates intestinal inflammation. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $696,020 | March 16, 2020 | February 28, 2027 | BURGESS, STACEY L | reporter.nih.gov |
| Evaluation of Memory Responses and Biomarkers from a Phase 1 Enterotoxigenic Escherichia coli (ETEC) Intramuscular Subunit Vaccine with dmLT Adjuvant | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $685,989 | May 24, 2021 | April 30, 2023 | NORTON, ELIZABETH B | reporter.nih.gov |
| Mechanisms of Gastrointestinal Post-Inflammatory Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $684,000 | June 1, 2020 | May 31, 2025 | VERNE, GEORGE NICHOLAS | reporter.nih.gov |
| Quorum Sensing Regulation of EHEC Virulence Genes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $668,955 | July 1, 2003 | May 31, 2022 | SPERANDIO, VANESSA | reporter.nih.gov |
| Genomic Epidemiology of Campylobacter in Poultry to Enable the Effective Control of Human Campylobacteriosis in a Middle Income Country | NIH | Fogarty International Center | 2022 to 2025 | $659,105 | August 1, 2022 | June 30, 2027 | SCHIAFFINO, FRANCESCA | reporter.nih.gov |
| Regulation of enteric norovirus infection by host-derived and microbiota-transformed bile acids | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $642,669 | November 25, 2018 | July 31, 2025 | KARST, STEPHANIE M | reporter.nih.gov |
| Enhancement and Maintenance of the HEALS cohort | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $642,236 | September 30, 2017 | June 30, 2023 | AHSAN, HABIBUL | reporter.nih.gov |
| Sugar regulation of EHEC virulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $638,835 | July 1, 2020 | June 30, 2022 | SPERANDIO, VANESSA | reporter.nih.gov |
| Prevention of Paralytic Shellfish Poisoning in Subsistence Shellfish Harvest Communities of Southeast Alaska | NIH | National Institute of Environmental Health Sciences | 2022 to 2024 | $636,597 | April 26, 2024 | May 31, 2025 | GRIBBLE, MATTHEW O. | reporter.nih.gov |
| Salmonella-specific therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $635,257 | August 15, 2018 | July 31, 2023 | AHMER, BRIAN M | reporter.nih.gov |
| The Role of Macrophages in Immune Responses to Giardia | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $612,377 | July 1, 2014 | July 31, 2025 | SINGER, STEVEN M | reporter.nih.gov |
| Rewiring networks for a pathogenic lifestyle | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $609,924 | September 1, 2023 | August 31, 2025 | DZIEJMAN, MICHELLE | reporter.nih.gov |
| Fabrication of Nanoscale Plastics and Effects on Intestinal Barrier Function In Vitro | NIH | National Institute of Environmental Health Sciences | 2022 to 2023 | $607,832 | August 1, 2022 | July 31, 2025 | FENNELL, TIMOTHY RAYMOND | reporter.nih.gov |
| Engineering a Small Intestinal Microbiome to Evaluate Food Additive Exposure | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $606,284 | July 1, 2018 | June 30, 2024 | MAHLER, GRETCHEN | reporter.nih.gov |
| Curing chronic Toxoplasma infection with novel and potent protease inhibitors | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $603,601 | August 1, 2025 | July 31, 2030 | CARRUTHERS, VERNON BRUCE | reporter.nih.gov |
| Salmonella Host interactions | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $601,256 | June 15, 1999 | October 31, 2029 | BAUMLER, ANDREAS J | reporter.nih.gov |
| Rhamnolipid-Based Remediation Technologies for Uranium and Rare Earth Element Contamination | NIH | National Institute of Environmental Health Sciences | 2021 | $600,000 | May 5, 2020 | April 30, 2023 | BOXLEY, CHETT J | reporter.nih.gov |
| Hepatoselective Dihydroquinolizinone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $600,000 | April 10, 2023 | March 31, 2025 | DU, YANMING | reporter.nih.gov |
| Development of proprietary bacteriophage Qbeta as a vaccine carrier platform for anti-salmonella vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $594,562 | July 9, 2021 | June 30, 2024 | KAVUNJA, HERBERT WANJALA | reporter.nih.gov |
| Application of Data Science to Build Research Capacity in Zoonoses and Food-Borne Infections in West Africa | NIH | Fogarty International Center | 2023 to 2025 | $593,208 | September 1, 2023 | May 31, 2026 | SAMPANE-DONKOR, ERIC | reporter.nih.gov |
| Zeiss LSM 980 Airyscan 2 laser scanning confocal microscope | NIH | Office of the Director, National Institutes of Health | 2023 | $593,045 | May 1, 2023 | April 30, 2024 | ALTO, NEAL MATHEW | reporter.nih.gov |
| Data to Action: A Secondary School-based Citizen Science Project to Address Arsenic Contamination of Well Water | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $584,174 | August 17, 2018 | June 30, 2023 | DISNEY, JANE ELIZABETH | reporter.nih.gov |
| Dissecting Mechanisms of Granuloma Macrophage Polarization and Granuloma Formation in Chronic Salmonella Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $582,876 | January 17, 2019 | December 31, 2023 | PHAM, TRUNG HOANG MINH | reporter.nih.gov |
| The effects of depleted uranium shrapnel on mitochondrial cellular function, administrative diversity supplement | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $574,711 | January 12, 2022 | April 30, 2025 | SALANGA, MATTHEW | reporter.nih.gov |
| Maternally acquired immunity in protection against enterotoxigenic E. coli infections in infants | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $571,071 | August 14, 2024 | July 31, 2025 | CHAKRABORTY, SUBHRA | reporter.nih.gov |
| Ovarian disrupting effects of per-and polyfluoroalkyl substances (PFAS) on gonadotropin-dependent folliculogenesis and ovulation | NIH | National Institute of Environmental Health Sciences | 2025 | $561,584 | December 13, 2024 | October 31, 2029 | XIAO, SHUO | reporter.nih.gov |
| The Role of Aquaporin 3 in Arsenic-Induced DNA Damage and Mutagenesis | NIH | National Institute of Environmental Health Sciences | 2022 to 2024 | $554,831 | August 15, 2022 | November 3, 2024 | XIA, JUN | reporter.nih.gov |
| Phylodynamics of Shiga Toxin-Producing Escherichia coli from Local Sources | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $550,254 | May 2, 2022 | April 30, 2027 | TARR, GILLIAN | reporter.nih.gov |
| Protecting the Health of Future Generations: Assessing and Preventing Exposures to Endocrine-Disrupting Flame Retardant Chemicals & PCBs in Two Alaska Native Arctic Communities on St. Lawrence Island | NIH | National Institute of Environmental Health Sciences | 2021 | $544,266 | August 8, 2011 | June 30, 2025 | MILLER, PAMELA KAY | reporter.nih.gov |
| Arsenic-Induced miRNA-199 and mriRNA-214 Deplete Mitochondrial DNA for the Generation of Cancer Stem-Like Cells | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $543,060 | September 20, 2021 | May 31, 2024 | CHEN, FEI | reporter.nih.gov |
| Protecting children's health by applying novel approaches to assess urban and rural drinking water | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $542,748 | August 2, 2023 | July 31, 2027 | GARCIA-JARAMILLO, MANUEL | reporter.nih.gov |
| Microbial mechanisms of methylmercury metabolism in humans | NIH | National Institute of Environmental Health Sciences | 2021 | $538,053 | September 19, 2019 | August 31, 2024 | RAND, MATTHEW D | reporter.nih.gov |
| Prevention of Paralytic Shellfish Poisoning in Subsistence Shellfish Harvest Communities of Southeast Alaska | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $536,323 | March 17, 2022 | February 19, 2024 | GRIBBLE, MATTHEW O. | reporter.nih.gov |
| Impact of breastmilk on Campylobacter jejuni survival | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $534,418 | August 1, 2025 | July 31, 2030 | SZYMANSKI, CHRISTINE M. | reporter.nih.gov |
| Structure and Function of the Salmonella type III secretion sorting platform | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $531,245 | January 13, 2025 | December 31, 2029 | LARA-TEJERO, MARIA | reporter.nih.gov |
| Epidemiology and Genomics of Multidrug resistant Salmonella Typhi infections in Kenya: The role of carriage in an endemic setting | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $528,391 | February 15, 2013 | March 31, 2025 | KARIUKI, SAMUEL M | reporter.nih.gov |
| Molecular mechanism of V. vulnificus MARTX toxin in pathogenesis and food safety | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $519,980 | July 1, 2011 | October 31, 2021 | SATCHELL, KARLA J F | reporter.nih.gov |
| Development of a handheld PEST-pen device for the rapid detection of organophosphate insecticides on food and clothing | NIH | National Institute of Environmental Health Sciences | 2021 | $515,084 | March 1, 2018 | August 31, 2024 | ROSENBERG, YVONNE J | reporter.nih.gov |
| Sustainable One Health Research Training Capacity: Molecular Epidemiology of Zoonotic Foodborne and Waterborne Pathogens in Eastern Africa | NIH | Fogarty International Center | 2021 to 2022 | $514,922 | June 1, 2010 | May 31, 2024 | GEBREYES, WONDWOSSEN A. | reporter.nih.gov |
| A chemical strategy for inhibiting Vibrio quorum sensing and virulence. | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $503,887 | September 1, 2025 | August 31, 2026 | VAN KESSEL, JULIA C. | reporter.nih.gov |
| A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $501,201 | September 1, 2023 | July 31, 2027 | HARR, JENNIFER | reporter.nih.gov |
| Deciphering the pathogenesis of an enteric pathogen in neonatal and immunodeficient mice | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $497,998 | August 11, 2022 | April 30, 2027 | CABALLERO FLORES, GUSTAVO | reporter.nih.gov |
| Role of Aflatoxin-induced DNA Damage Formation and Repair in Hepatic Mutagenesis | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $497,335 | September 3, 2020 | August 31, 2025 | LI, WENTAO | reporter.nih.gov |
| Adolescent exposure to PCBs as a risk factor for the development of depression | NIH | National Institute of Environmental Health Sciences | 2025 | $495,980 | December 17, 2024 | October 31, 2029 | TOBOREK, MICHAL | reporter.nih.gov |
| Vesicle-Cloaked Virus Clusters as Emerging Pathogens: Will They Challenge Current Disinfection Paradigm? | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $489,586 | September 23, 2021 | August 31, 2024 | SHUAI, DANMENG | reporter.nih.gov |
| Subversion of Syndecan-1 Functions in Listeriosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $486,750 | December 15, 2020 | November 30, 2024 | PARK, PYONG WOO | reporter.nih.gov |
| Bacterial modulation of noncanonical inflammasome | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $484,035 | January 16, 2018 | August 31, 2025 | KAILASAN VANAJA, SIVAPRIYA | reporter.nih.gov |
| Identification of Host and Viral Determinants of Human Norovirus B cell Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $477,833 | December 1, 2016 | November 30, 2022 | KARST, STEPHANIE M | reporter.nih.gov |
| Signaling through intestinal MUC receptors by bacterial Serine Proteases of Enterobacteriaceae | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $474,419 | May 23, 2022 | April 30, 2025 | RUIZ, FERNANDO | reporter.nih.gov |
| Semi-continuous, on-line monitoring of selenium in coal-fired power plant waste water | NIH | National Institute of Environmental Health Sciences | 2021 | $473,190 | August 1, 2020 | March 31, 2023 | PETERMAN, MARK C | reporter.nih.gov |
| Outer Membrane Vesicles in Shiga Toxin-Mediated Inflammatory and Thrombotic Responses Leading to Systemic Disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $470,530 | July 5, 2023 | June 30, 2025 | LEONG, JOHN M | reporter.nih.gov |
| Environmental adaptation by Vibrio cholerae | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $467,277 | August 1, 2018 | March 5, 2023 | BINA, JAMES EDWARD | reporter.nih.gov |
| Spatiotemporal Regulation of Protrusion Dynamics During Intracellular Bacterial Dissemination | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $462,053 | July 17, 2023 | June 30, 2025 | HIGGINS, DARREN E | reporter.nih.gov |
| Discovery of fungus-derived natural products as new and effective Antigiardial agents. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $460,734 | April 5, 2024 | February 28, 2027 | OJO, KAYODE K | reporter.nih.gov |
| Campylobacter jejuni restriction by the intestinal microbiota | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $460,625 | August 17, 2023 | July 31, 2025 | GALAN, JORGE E | reporter.nih.gov |
| Effects of Salmonella infection on bone marrow macrophage progenitors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $460,049 | May 14, 2021 | October 31, 2023 | CHERAYIL, BOBBY JOSEPH | reporter.nih.gov |
| Exposure to endocrine disrupting chemicals via consumption of ultraprocessed foods: implications for maternal metabolic health in pregnancy | NIH | National Institute of Environmental Health Sciences | 2025 | $459,522 | July 15, 2025 | June 30, 2027 | STRAKOVSKY, RITA S. | reporter.nih.gov |
| Cryptosporidium's polyketide secondary metabolite: exogenous production, compound characterization and function in intracellular development. | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $459,371 | July 1, 2022 | June 30, 2025 | O'CONNOR, ROBERTA M | reporter.nih.gov |
| The roles of glutathione metabolism in growth and virulence of Listeria monocytogenes | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $453,750 | July 25, 2022 | June 30, 2025 | BELITSKY, BORIS R | reporter.nih.gov |
| Impact of Per/Polyfluoroalkyl pollutants on vascular disease mechanisms | NIH | National Institute of Environmental Health Sciences | 2023 | $453,750 | July 1, 2023 | June 30, 2025 | GOKCE, NOYAN | reporter.nih.gov |
| Characterization of virulence factors in shigellosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $451,821 | July 1, 2023 | June 30, 2026 | AGAISSE, HERVE F | reporter.nih.gov |
| Cryptosporidium mutagenesis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $449,915 | July 21, 2023 | August 31, 2025 | WIDMER, GIOVANNI | reporter.nih.gov |
| The impact of maternal cyanotoxin ingestion on the development and function of the stress axis in offspring | NIH | National Institute of Environmental Health Sciences | 2024 | $448,383 | August 16, 2024 | July 31, 2027 | CHUNG, WILSON | reporter.nih.gov |
| Evaluating mechanisms of sex differences in environmentally-induced metabolic diseases | NIH | National Institute of Environmental Health Sciences | 2022 to 2024 | $447,682 | June 3, 2022 | May 31, 2025 | WAHLANG, BANRIDA | reporter.nih.gov |
| Investigating Trophic Exposure to Marine Microplastics and Plasticizers in a Sentinel Species and the Implications for Seafood Safety | NIH | National Institute of Environmental Health Sciences | 2022 | $447,164 | June 16, 2022 | December 15, 2025 | HART, LESLIE B. | reporter.nih.gov |
| Defining mechanisms of Casp1/11-independent death triggered by clinical Salmonella Enteritidis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $446,875 | March 1, 2022 | February 29, 2024 | BRODSKY, IGOR E | reporter.nih.gov |
| Impact of CRISPR-associated transposons on anti-phage immunity in Vibrio cholerae | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $445,500 | February 1, 2022 | August 31, 2024 | STERNBERG, SAMUEL HENRY | reporter.nih.gov |
| Subunit Vaccine for Cryptosporidiosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $444,125 | December 7, 2020 | November 30, 2023 | PETRI, WILLIAM A | reporter.nih.gov |
| Using microbiomes as microsensors to forecast toxic algae blooms | NIH | National Institute of Environmental Health Sciences | 2022 to 2023 | $443,179 | May 10, 2022 | April 30, 2025 | NUNN, BROOK LEANNE | reporter.nih.gov |
| Evaluation of novel in vitro and in vivo models to characterize anti-Shigella therapeutic PK/PD relationships | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $443,174 | July 23, 2021 | June 30, 2023 | ARNOLD, SAMUEL L | reporter.nih.gov |
| Reactivation of Chronic Toxoplasmosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $443,122 | February 1, 2021 | January 31, 2023 | SIBLEY, L. DAVID | reporter.nih.gov |
| Mechanistic evaluation of resistance to sulfite toxicity in Salmonella | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $442,250 | June 6, 2023 | May 31, 2026 | ELFENBEIN, JOHANNA REBECCA | reporter.nih.gov |
| Arsenic's effects on the intestinal stem cell niche | NIH | National Institute of Environmental Health Sciences | 2021 | $441,662 | February 1, 2021 | January 31, 2025 | BAIN, LISA J | reporter.nih.gov |
| Role of tissue kallikrein in alternative complement pathway activation in STEC-HUS | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $441,375 | June 1, 2024 | April 30, 2027 | SARTAIN, SARAH ELIZABETH | reporter.nih.gov |
| Defining human gut microbiome-mediated protection against Shigella infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $441,375 | May 23, 2024 | March 31, 2026 | WOLF, ASHLEY ROBIN | reporter.nih.gov |
| Programming of Epigenetic Clocks and Biomarkers from Early-life Arsenic Exposure | NIH | National Institute of Environmental Health Sciences | 2023 to 2024 | $440,853 | September 7, 2023 | August 31, 2025 | CARDENAS, ANDRES | reporter.nih.gov |
| Gigiigooinaan (Our Fish): A New Advisory to Promote Anishinaabe Health and Wellness | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $440,762 | July 1, 2018 | March 31, 2025 | DELLINGER, MATTHEW J | reporter.nih.gov |
| Understanding the role of bedrock, settlement patterns, and water quality in human health equity | NIH | National Institute of Environmental Health Sciences | 2024 | $440,000 | August 16, 2024 | July 31, 2026 | MUELLER, JOEL THOMAS | reporter.nih.gov |
| Metabolic Interactions between Salmonella and E. coli Nissle 1917 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $439,250 | July 11, 2022 | June 30, 2025 | WINTER, SEBASTIAN E | reporter.nih.gov |
| Generation of CD8+ Tissue-Resident Memory T cell response during Yersinia pseudotuberculosis foodborne infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $438,625 | June 26, 2023 | May 31, 2025 | ZHANG, YUE | reporter.nih.gov |
| Novel effector protein functions encoded by T3SS positive V. cholerae | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $437,198 | July 14, 2017 | June 30, 2024 | DZIEJMAN, MICHELLE | reporter.nih.gov |
| sRNAs in EHEC virulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $434,567 | May 20, 2021 | April 30, 2024 | KENDALL, MELISSA | reporter.nih.gov |
| Developing effective nanovaccines against pathogenic Escherichia coli | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $434,500 | June 1, 2021 | May 31, 2025 | TORRES, ALFREDO G | reporter.nih.gov |
| Membrane-cloaked nanoparticles as mucosal vaccines against giardiasis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $434,500 | September 24, 2021 | August 31, 2024 | ECKMANN, LARS | reporter.nih.gov |
| RNA helicases in bacterial pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $434,403 | March 1, 2021 | February 29, 2024 | KENDALL, MELISSA | reporter.nih.gov |
| Rapid and Simple Paper Diagnostic Test to Detect Enteric Pathogens in the Developing World | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $433,570 | September 1, 2023 | August 31, 2025 | KIM, CHANG HEE | reporter.nih.gov |
| Evaluation of a point-of-care immunochromatographic assay for enteric fever | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $433,239 | April 13, 2021 | March 31, 2024 | CHARLES, RICHELLE C | reporter.nih.gov |
| Regulation of the Vibrio cholerae MSHA Pilus Drives Host Colonization and Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $432,741 | July 2, 2024 | June 30, 2027 | FLOYD, KYLE A | reporter.nih.gov |
| Bioelectricity in Gut Epithelium Drives Pathogenic Bacterial Targeting | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $431,750 | June 21, 2021 | November 30, 2023 | ZHAO, MIN | reporter.nih.gov |
| Role of the gut metabolite lactate on Campylobacter jejuni pathogenicity | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $431,750 | November 16, 2023 | October 31, 2025 | DIRITA, VICTOR J. | reporter.nih.gov |
| Microbiome Impact on the Susceptibility and Severity to Cryptosporidium Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $429,875 | February 2, 2021 | January 31, 2023 | MEAD, JAN R | reporter.nih.gov |
| Structural mapping of an immunodominant antigenic site on the norovirus capsid | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $429,750 | July 10, 2024 | May 31, 2027 | DUBOIS, REBECCA MICHELLE | reporter.nih.gov |
| m6A mRNA reader proteins in the AIDS-opportunistic pathogen Toxoplasma gondii | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $429,577 | January 3, 2023 | December 31, 2025 | SULLIVAN, WILLIAM J | reporter.nih.gov |
| TNRSF13B polymorphisms and the control of innate B cell responses – a double edged sword | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $429,000 | January 19, 2021 | December 31, 2023 | CASCALHO, MARILIA ISABEL | reporter.nih.gov |
| A System to Study Salmonella Typhi Infection and Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $429,000 | March 1, 2021 | February 29, 2024 | ALUGUPALLI, KISHORE R | reporter.nih.gov |
| Mechanisms of Pathogenesis in Giardiasis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $429,000 | September 24, 2021 | August 31, 2024 | SINGER, STEVEN M | reporter.nih.gov |
| Methods to study Cryptosporidium drug resistance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $429,000 | November 14, 2022 | October 31, 2025 | HUSTON, CHRISTOPHER D | reporter.nih.gov |
| m6A methylation of IRGM transcripts in epithelial-Cryptosporidium interactions | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $428,575 | February 14, 2024 | December 31, 2026 | CHEN, XIAN-MING | reporter.nih.gov |
| Defining astrovirus-specific T cell responses | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $428,534 | March 1, 2023 | February 28, 2025 | BALDRIDGE, MEGAN T | reporter.nih.gov |
| Cryptosporidiosis and Oral Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $427,876 | June 23, 2023 | May 31, 2025 | SIBLEY, L. DAVID | reporter.nih.gov |
| Antiviral inhibition of ZCCHC14-TENT4 complex in hepatitis A virus infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $427,625 | August 5, 2021 | July 31, 2023 | LI, YOU | reporter.nih.gov |
| Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $427,625 | August 16, 2023 | July 31, 2025 | DING, SIYUAN | reporter.nih.gov |
| Antiparasitic metabolites from deep subterranean fungi for the treatment of cryptosporidiosis, an AIDS defining disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $426,250 | March 1, 2023 | February 28, 2026 | SALOMON, CHRISTINE E | reporter.nih.gov |
| Targeting T3SA proteins as protective antigens against Yersinia | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $425,855 | January 24, 2023 | December 31, 2025 | PICKING, WENDY L. | reporter.nih.gov |
| Atmospheric transformation of harmful cyanobacterial algae and novel mechanisms of pulmonary toxicity | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $425,512 | September 1, 2024 | August 31, 2027 | SABO-ATTWOOD, TARA L | reporter.nih.gov |
| Salmonella chronic infection: Biofilm matrix factors and innate immune tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $423,500 | December 17, 2020 | November 30, 2023 | GUNN, JOHN S | reporter.nih.gov |
| Protein phosphorylation and Campylobacter jejuni pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $423,500 | April 11, 2022 | March 31, 2025 | THOMPSON, STUART A | reporter.nih.gov |
| Protective roles of CD180 and NOD1 in the protective immunity against cerebral Toxoplasma infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $423,500 | July 15, 2025 | June 30, 2027 | SUZUKI, YASUHIRO | reporter.nih.gov |
| Rational design of CNS-permeable cathepsin L inhibitors for treatment of chronic toxoplasmosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $423,128 | December 1, 2016 | November 30, 2022 | CARRUTHERS, VERNON BRUCE | reporter.nih.gov |
| Defining a novel protein network for Toxoplasma repurposing of host ESCRT machinery | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $421,980 | January 4, 2024 | November 30, 2025 | CARRUTHERS, VERNON BRUCE | reporter.nih.gov |
| Effect of drinking water treatment on bacterial strain sharing among Kenyan children | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $421,396 | June 1, 2022 | May 31, 2024 | PICKERING, AMY J. | reporter.nih.gov |
| Regulation of cyst formation in the AIDS opportunistic pathogen Toxoplasma | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $420,880 | November 1, 2021 | October 31, 2024 | SULLIVAN, WILLIAM J | reporter.nih.gov |
| Dissemination of intracellular and extracellular Listeria from the gut | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $420,750 | June 4, 2021 | May 31, 2025 | D'ORAZIO, SARAH E. F. | reporter.nih.gov |
| Pyroptotic Macrophages Traps Against Shigella Infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $420,750 | August 25, 2023 | July 31, 2025 | AACHOUI, YOUSSEF | reporter.nih.gov |
| Toxoplasma sporozoite genes that determine environmental resistance and invasion of host cells. | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $419,215 | May 24, 2022 | April 30, 2025 | SAEIJ, JEROEN | reporter.nih.gov |
| Deciphering the Pathogenesis of EHEC Infection and the Effects of Bacteria-Based Therapies Using Comparative Gut-on-a-Chip | NIH | Office of the Director, National Institutes of Health | 2022 to 2023 | $419,154 | May 1, 2022 | April 30, 2025 | AMBROSINI, YOKO MIYAMOTO | reporter.nih.gov |
| Human Cellular Immune Programming Against Invasive Salmonella | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $418,512 | August 5, 2019 | July 31, 2024 | RAPAKA, REKHA R | reporter.nih.gov |
| Metabolic changes that promote adaptation of Listeria monocytogenes to oxidative stress and preserving intracellular redox homeostasis | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $418,270 | December 6, 2023 | November 30, 2026 | ABDELHAMED, HOSSAM A | reporter.nih.gov |
| Community-engaged environmental monitoring for biowaste treatment transitions | NIH | National Institute of Environmental Health Sciences | 2023 | $417,878 | July 19, 2023 | June 30, 2025 | CHO, SEUNG-HYUN | reporter.nih.gov |
| Vaccine induction of Salmonella-specific Th1 memory cells | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $416,649 | September 26, 2024 | August 31, 2026 | MCSORLEY, STEPHEN J | reporter.nih.gov |
| Cellular and Molecular Mechanisms of Arsenic-Induced Urothelial Bladder Cancer | NIH | National Cancer Institute | 2024 to 2025 | $415,524 | March 1, 2024 | February 28, 2026 | LEACH, STEVEN D | reporter.nih.gov |
| Biotype-specific evolution | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $414,860 | January 6, 2023 | December 31, 2025 | WITHEY, JEFFREY H | reporter.nih.gov |
| Identification of Listeria monocytogenes immune evasion mechanisms | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $414,305 | November 4, 2022 | October 31, 2025 | SAUER, JOHN-DEMIAN | reporter.nih.gov |
| The Role of TamAB in Salmonella Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $413,738 | June 1, 2021 | May 31, 2024 | SLAUCH, JAMES M. | reporter.nih.gov |
| Regulation of the Salmonella Pathogenicity Island 1 Type III Secretion System via the hilD 3' untranslated region | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $413,290 | May 20, 2022 | April 30, 2024 | SLAUCH, JAMES M. | reporter.nih.gov |
| Iron regulation of chronic Toxoplasma gondii infection and immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $413,010 | March 2, 2021 | March 31, 2023 | GIGLEY, JASON | reporter.nih.gov |
| "ahbahjipdooneh woolibahmowsoowahkn": reclaiming indigenous health through water and food sovereignty | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2024 | $411,833 | September 25, 2023 | December 31, 2025 | FORD, TIMOTHY EDGCUMBE | reporter.nih.gov |
| New insights into early T cell protection during acute toxoplasmosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $411,428 | June 2, 2022 | May 31, 2025 | DENKERS, ERIC Y | reporter.nih.gov |
| Defining the shared transcriptional network underlying Toxoplasma extracellular stress and stage transition | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $410,932 | September 6, 2023 | August 31, 2025 | GUBBELS, MARC-JAN | reporter.nih.gov |
| Identification and characterization of early encystation genes in the human parasite Entamoeba histolytica | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $410,029 | July 3, 2023 | June 30, 2026 | INGRAM-SMITH, CHERYL JEAN | reporter.nih.gov |
| Occidiofungin as a new lead against the enteric AIDS-OI cryptosporidium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $409,327 | April 1, 2021 | March 31, 2024 | VEMULAPALLI, RAMESH | reporter.nih.gov |
| The Role of G Protein-coupled Receptors in Red Tide Dinoflagellate Bioluminescence | NIH | National Institute of Environmental Health Sciences | 2023 | $406,843 | August 23, 2023 | July 31, 2025 | YE, LIBIN | reporter.nih.gov |
| Engagement of the macrophage integrated stress response in Salmonella infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $406,593 | November 13, 2023 | October 31, 2025 | O'RIORDAN, MARY | reporter.nih.gov |
| Gastroenteritis virus infections in South African children: secretor status-linkedsusceptibility, prevalence and genetic diversity and humoral responses to norovirusinfection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $403,050 | April 17, 2023 | March 31, 2028 | MANS, JANET | reporter.nih.gov |
| A collaborative cross mouse model of Salmonella Typhi Chronic Carriage | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $402,985 | August 1, 2025 | July 31, 2027 | GUNN, JOHN S | reporter.nih.gov |
| Applied Metatranscriptomics and Metatranslatomics to identify new mechanisms of Salmonella-microbiota competition | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $402,328 | May 16, 2024 | March 31, 2027 | RAFFATELLU, MANUELA | reporter.nih.gov |
| Structure and Function of DcrB, an Enterobacterial Copper Resistance Protein | NIH | National Institute of General Medical Sciences | 2024 | $401,680 | February 15, 2024 | January 31, 2027 | MAY, JOHN | reporter.nih.gov |
| Microbiome and E. coli O157:H7 infection of human gut tissue | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $401,250 | August 15, 2018 | July 31, 2023 | WEISS, ALISON A. | reporter.nih.gov |
| Developmental Origins of Neurotoxicity of the PFAS GenX | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $400,488 | April 14, 2021 | March 31, 2024 | FREEMAN, JENNIFER L. | reporter.nih.gov |
| Development of prion protein-lowering divalent siRNA therapy for prion disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $399,878 | December 15, 2020 | November 30, 2021 | MINIKEL, ERIC VALLABH | reporter.nih.gov |
| Harnessing iron acquisition to hinder enterobacterial pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $399,521 | June 1, 2015 | March 31, 2023 | RAFFATELLU, MANUELA | reporter.nih.gov |
| Neuroinflammation during cerebral Toxoplasma gondii infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $395,338 | March 17, 2021 | March 1, 2025 | LODOEN, MELISSA BRUCKNER | reporter.nih.gov |
| Phage mobilization and microbiota dynamics driving colonization resistance to Vibrio cholerae invasion | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $393,008 | December 1, 2023 | October 31, 2026 | DEGNAN, PATRICK H | reporter.nih.gov |
| Deciphering mechanisms of Listeria placental-fetal invasion | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $391,795 | July 14, 2021 | June 14, 2022 | FREITAG, NANCY ELIZABETH | reporter.nih.gov |
| A bacterial biosensor for intracellular metal availability in the gut | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $390,578 | April 22, 2022 | March 31, 2025 | KNODLER, LEIGH | reporter.nih.gov |
| Marine Neurotoxins: Examining the impacts of a pedagogically focused RET model that explores the interplay of marine biotoxins, commercial shellfish aquaculture, and public health safety | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $390,531 | December 9, 2022 | October 31, 2027 | IMONDI, RALPH | reporter.nih.gov |
| Murine Model of Human Hepatitis A | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $388,750 | March 6, 2017 | February 28, 2022 | LEMON, STANLEY M. | reporter.nih.gov |
| Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped Hepatovirus | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $388,750 | September 24, 2012 | August 31, 2023 | LEMON, STANLEY M. | reporter.nih.gov |
| Mechanisms for Vibrio cholerae colonization and pathogenesis in zebrafish | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $386,000 | May 5, 2017 | April 30, 2023 | WITHEY, JEFFREY H | reporter.nih.gov |
| Toxicant disruption of receptor-mediated endocytosis in oogenesis and later life metabolic dysfunction | NIH | National Institute of Environmental Health Sciences | 2021 | $384,737 | September 1, 2017 | August 31, 2024 | TIMME-LARAGY, ALICIA R | reporter.nih.gov |
| Targeting antibiotic resistance genes in Vibrio cholerae using a phage-encoded CRISPR-Cas system to improve efficacy of phage prophylaxis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $383,168 | January 1, 2021 | December 31, 2023 | YEN, MINMIN | reporter.nih.gov |
| Ex vivo skin wound infection model for Vibrio vulnificus pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $379,800 | May 23, 2024 | March 31, 2026 | VAN KESSEL, JULIA C. | reporter.nih.gov |
| Genomic features of host adaptation of Campylobacter in low-income settings | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $378,297 | May 1, 2022 | April 30, 2024 | KOSEK, MARGARET N | reporter.nih.gov |
| Naso-oropharyngeal Brucella Infections and Mucosal Immune Protection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $376,668 | August 17, 2017 | December 31, 2023 | PASCUAL, DAVID W | reporter.nih.gov |
| Cancer Risks from Unregulated Contaminants of Public Water Systems | NIH | National Cancer Institute | 2025 | $376,314 | August 8, 2025 | July 31, 2028 | DE ROOS, ANNECLAIRE J | reporter.nih.gov |
| Environmental Arsenic Exposure and Hematotoxicity | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $371,250 | August 1, 2022 | June 30, 2024 | MEDINA, SEBASTIAN | reporter.nih.gov |
| Exposure to Per- and Polyfluoroalkyl Substances and Prostate Cancer: Opportunities for Prevention and Early Detection | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $369,833 | March 1, 2024 | February 28, 2027 | IYER, HARI S | reporter.nih.gov |
| Arsenic Exposure and its Association with Cancers among Residents with Wells in New Mexico's Border Counties | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $363,958 | July 15, 2024 | June 30, 2028 | RAHMAN, HUMAIRAT H | reporter.nih.gov |
| Glutarate metabolism in Salmonella | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $362,767 | July 1, 2022 | August 31, 2024 | WINTER, SEBASTIAN E | reporter.nih.gov |
| Mechanisms underlying diarrhea and gut inflammation mediated by Enterotoxigenic and Enteropathogenic E. coli | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $361,988 | August 18, 2023 | July 31, 2027 | VISWESWARIAH, SANDHYA | reporter.nih.gov |
| Innovative Point-of-Use Water Purification System: Portable, Scalable, Efficient, Easy-Use | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $361,872 | September 1, 2024 | August 31, 2025 | LI, HUIFENG | reporter.nih.gov |
| Gut microbiome-mediated small-molecule signaling and resistance to invading microorganisms | NIH | National Institute of General Medical Sciences | 2021 | $359,191 | August 11, 2017 | July 31, 2023 | HSIAO, ANSEL | reporter.nih.gov |
| Mucosal associated invariant T (MAIT) cells in Vibrio cholerae infection and vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $359,000 | June 22, 2017 | May 31, 2023 | LEUNG, DANIEL TED | reporter.nih.gov |
| Role of reactive oxygen species in controlling T. gondii acute infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $358,989 | July 24, 2024 | June 30, 2028 | LIMA, TATIANE S. | reporter.nih.gov |
| Reduced Reactive Oxygen Species and Oxidative Phosphorylation in Arsenic-Induced Cancer Stem Cells | NIH | National Institute of Environmental Health Sciences | 2021 | $355,512 | September 14, 2021 | June 30, 2023 | CHEN, FEI | reporter.nih.gov |
| Biological vector borne transmission of Salmonella by cockroaches | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $355,316 | November 1, 2022 | October 31, 2027 | PIETRI, JOSE ENRIQUE | reporter.nih.gov |
| Humoral Immunity to Enteric Viruses among Infants and Mothers in Bangladesh | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $350,250 | July 19, 2024 | May 31, 2026 | CAMERINI, DAVID | reporter.nih.gov |
| Arsenic, GATA-1, and Hematotoxicity | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $346,542 | April 1, 2018 | June 30, 2022 | LIU, KE JIAN | reporter.nih.gov |
| Modeling the Impact of Interventions to Reduce Typhoidal Salmonella Transmission in the Indo-Pacific. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $338,055 | September 11, 2024 | August 31, 2029 | HOFFMAN, SETH ARI SIM-SON | reporter.nih.gov |
| Modernization of the Ohio State University Bevis Hall Zebrafish Facility | NIH | Office of the Director, National Institutes of Health | 2024 | $337,482 | June 15, 2024 | June 14, 2025 | HAESEMEYER, MARTIN | reporter.nih.gov |
| The molecular epidemiology of enteropathogenic (EPEC) and enteroaggregative (EAEC) Escherichia coli among adult patients in Seattle | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $326,678 | August 8, 2024 | July 31, 2029 | TANSARLI, GIANNOULA | reporter.nih.gov |
| Associations between Perfluoroalkyl Substances (PFAS) Exposure and Aeroallergen Sensitization among Infants at High-Risk for Developing Asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $322,632 | January 1, 2024 | December 31, 2028 | JACKSON-BROWNE, MEDINA SAMIRA | reporter.nih.gov |
| A Human Enteroid Model of Cholera Toxin Pathophysiology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $316,440 | January 9, 2018 | November 30, 2023 | FOULKE-ABEL, JENNIFER | reporter.nih.gov |
| Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $315,132 | July 1, 2013 | June 30, 2024 | HOUPT, ERIC R | reporter.nih.gov |
| Ultra-Sensitive, Rapid, Point-of-Use (POU) Mercury Sensor Enabled by Light-Pinpointed Enrichment | NIH | National Institute of Environmental Health Sciences | 2025 | $314,745 | September 17, 2025 | August 31, 2027 | FAN, DONGLEI EMMA | reporter.nih.gov |
| Wastewater data integration and modelling to accurately predict community and organizational outbreaks due to viral pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $314,613 | March 11, 2022 | April 30, 2023 | TINTLE, NATHAN L | reporter.nih.gov |
| SBIR Phase I: Evaluating the Feasibility of a HAA-Meter for Affordable, Onsite Monitoring of Haloacetic Acids in Drinking Water Plants with Advanced Machine Learning Chromatographic Interpretation | NIH | National Institute of Environmental Health Sciences | 2025 | $309,285 | September 1, 2025 | August 31, 2026 | BRISTER, PAUL CLIFTON | reporter.nih.gov |
| Exposure to Mixtures of Emerging Contaminants in the Environment - Are Communities in Uganda at Health Risk?- A Case Study of Mbarara City. | NIH | Fogarty International Center | 2023 to 2025 | $308,407 | July 27, 2023 | April 30, 2028 | BIRUNGI, GRACE | reporter.nih.gov |
| One-step, in-the-field detection of water contamination by unhealthy concentrations of Endocrine Disrupting Chemicals affecting Nuclear Receptors arrayed on a test strip | NIH | National Institute of Environmental Health Sciences | 2024 | $306,872 | August 20, 2024 | July 31, 2025 | SCHAUFELE, FRED J | reporter.nih.gov |
| The role of manganese homeostasis in the nitric oxide stress response of Salmonella enterica serovar Typhimurium | NIH | National Institute of General Medical Sciences | 2022 | $306,869 | September 1, 2022 | August 31, 2025 | FRAWLEY, ELAINE R. | reporter.nih.gov |
| Arsenic Removal from the Body Through Mechanism-Guided Gut Microbiome Modulation | NIH | National Institute of Environmental Health Sciences | 2025 | $306,374 | September 12, 2025 | August 31, 2026 | ROGERS, JOHN | reporter.nih.gov |
| Rapid and economical system for preparation of PFAS samples to lower the Method Detection Limit | NIH | National Institute of Environmental Health Sciences | 2025 | $305,754 | September 10, 2025 | August 31, 2026 | ALBURTY, DAVID S | reporter.nih.gov |
| Portable, Rapid, Multiplexed Flow strip Test for Bacteria | NIH | National Institute of General Medical Sciences | 2021 | $303,163 | August 1, 2018 | April 30, 2024 | DEO, SAPNA K | reporter.nih.gov |
| An immunotherapeutic IgY formulation against norovirus diarrhea | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $300,000 | August 11, 2023 | July 31, 2024 | GOEPP, JULIUS G | reporter.nih.gov |
| Graphene-based Nanosensor Device for Rapid, Onsite Detection of Total Lead in Tap Water | NIH | National Institute of Environmental Health Sciences | 2024 | $300,000 | June 20, 2024 | May 31, 2025 | HILL, JAMES CURTIS | reporter.nih.gov |
| Scanning the Cryptosporidium proteome for vaccine antigens | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $299,999 | April 1, 2020 | March 31, 2023 | CAMPO, JOSEPH J. | reporter.nih.gov |
| Using novel pre-harvest, resistance-conferring treatments to prevent foodborne pathogenic outbreaks in produce | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $299,999 | July 25, 2022 | June 30, 2024 | MANOHAR, MURLI | reporter.nih.gov |
| Electrochemical POU Water Purification System | NIH | National Institute of Environmental Health Sciences | 2022 to 2023 | $299,719 | September 15, 2017 | January 31, 2026 | BOEHME, LINDSAY | reporter.nih.gov |
| Disaster-Ready Portable/Standalone Universal Water Purifier based on CER-ICP technology. | NIH | National Institute of Environmental Health Sciences | 2025 | $297,815 | December 5, 2024 | November 30, 2025 | YOON, JUNGHYO | reporter.nih.gov |
| Multiplexed Nuclear Receptor BioAssay platform to inexpensively and broadly survey the nation's water supply for contamination by endocrine disrupting chemicals | NIH | National Institute of Environmental Health Sciences | 2024 | $295,923 | March 5, 2024 | December 31, 2025 | SCHAUFELE, FRED J | reporter.nih.gov |
| Novel sorbents for removal of PFAS from water | NIH | National Institute of Environmental Health Sciences | 2024 | $295,923 | July 13, 2024 | June 30, 2026 | WEITKAMP, ROBIN | reporter.nih.gov |
| Public health priority setting for environmental metals mixtures and birth defects | NIH | National Institute of Environmental Health Sciences | 2022 | $289,545 | September 1, 2018 | May 31, 2024 | FRY, REBECCA | reporter.nih.gov |
| Public health priority setting for environmental metals mixtures and birth defects | NIH | National Institute of Environmental Health Sciences | 2021 | $289,474 | September 1, 2018 | May 31, 2023 | FRY, REBECCA | reporter.nih.gov |
| Maternal transfer factors and offspring development defects induced by nitrite | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $288,519 | June 1, 2024 | April 30, 2028 | HUERTAS, MAR | reporter.nih.gov |
| Fluorescence-Solid Phase Extraction (F-SPE) Platform for Rapid, On-site Detection of PFAS | NIH | National Institute of Environmental Health Sciences | 2023 | $276,312 | May 16, 2023 | April 30, 2024 | PATEL, DHRUV | reporter.nih.gov |
| Remediation of Perfluorinated Chemicals in Water Using Novel High-Affinity Polymer Adsorbents | NIH | National Institute of Environmental Health Sciences | 2022 to 2023 | $276,239 | April 1, 2018 | August 31, 2024 | BARIN, GOKHAN | reporter.nih.gov |
| Novel probiotics to mitigate xenobiotic toxicity through microbial biotransformation | NIH | National Institute of Environmental Health Sciences | 2023 | $275,765 | September 1, 2023 | August 31, 2025 | SOHEILYPOUR, MOHAMMAD | reporter.nih.gov |
| Defining the Intracellular Growth Niche of Foodborne Listeria monocytogenes | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $275,556 | March 1, 2020 | February 28, 2023 | D'ORAZIO, SARAH E. F. | reporter.nih.gov |
| The Development of Facial Motor Neuron Subtypes in Health and in Congenital Facial Weakness | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $274,321 | September 25, 2020 | November 30, 2026 | CARRILLO, GABRIELA LIZANA | reporter.nih.gov |
| The role of unobserved cholera: implications for prevention and control | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $270,000 | August 1, 2023 | July 31, 2025 | WIENS, KIRSTEN E | reporter.nih.gov |
| Feasibility study of novel hand hygiene formulations against bacterial spore infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $266,592 | September 19, 2022 | August 31, 2024 | HSU, STEPHEN | reporter.nih.gov |
| Regulatory mechanism of novel host-relevant biofilm formation protein in non-Cholera Vibrio species | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $263,920 | August 2, 2023 | July 31, 2025 | MILTON, MORGAN EILISE | reporter.nih.gov |
| Investigating the dynamics of Salmonella Typhi and bacteriophages in the environment and the human gut | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $262,664 | June 5, 2024 | April 30, 2029 | SAHA, SENJUTI | reporter.nih.gov |
| Turicibacter modifies intestinal infection severity by modulating intestinal metabolites | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $262,410 | August 1, 2025 | July 31, 2027 | ZHU, WENHAN | reporter.nih.gov |
| Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $261,163 | September 15, 2018 | June 30, 2024 | MARCINEK, DAVID J. | reporter.nih.gov |
| A Novel Approach for the At Home Detection of PFAS in Drinking Water | NIH | National Institute of Environmental Health Sciences | 2025 | $260,993 | June 1, 2025 | May 31, 2026 | OZDEMIR, R. OSMAN K. | reporter.nih.gov |
| Portable Scaled Sample Preparation Device for Concentration and Recovery of Bacterial Contaminants | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $259,553 | April 25, 2023 | March 31, 2025 | SU, XIAOLI | reporter.nih.gov |
| Infrared sensor for screening of emerging contaminants in water | NIH | National Institute of Environmental Health Sciences | 2022 | $259,502 | June 21, 2022 | January 31, 2024 | ROODENKO, ECATHERINA | reporter.nih.gov |
| An Online, Real-Time Microfluidic Biosensor for PFOA and PFOS | NIH | National Institute of Environmental Health Sciences | 2022 | $256,580 | December 1, 2021 | September 30, 2022 | CSICSERY, NICHOLAS | reporter.nih.gov |
| Large-scale data integration and harmonization to accurately predict sites facing future health-based drinking water crises | NIH | National Institute of Environmental Health Sciences | 2021 | $256,579 | April 1, 2021 | September 30, 2022 | TINTLE, NATHAN L | reporter.nih.gov |
| Develop a novel phase-change water/fluid purification technology that uses a NASA-validated vapor compression distillation (VCD) | NIH | National Institute of Environmental Health Sciences | 2022 | $255,208 | January 10, 2022 | June 30, 2023 | BITTERLY, STEVE | reporter.nih.gov |
| Effect of Shiga toxin, OMVs, and innate immune cells on epithelial integrity of human colonoids during EHEC infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $253,707 | February 21, 2020 | January 31, 2023 | LEONG, JOHN M | reporter.nih.gov |
| Epigenetic and genetic regulation of arsenic methylation and arsenic-relatedcardiovascular disease risk | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $251,694 | April 1, 2024 | March 31, 2026 | BOZACK, ANNE KRISTINA | reporter.nih.gov |
| Development of Novel Bacteriophages Targeting Enteric Bacterial Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $249,312 | September 1, 2020 | August 31, 2023 | FAHERTY, CHRISTINA S | reporter.nih.gov |
| Understanding the highly divergent mitochondrial ATP synthase in T. gondii | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $248,999 | April 1, 2020 | March 31, 2023 | HUET, DIEGO | reporter.nih.gov |
| Designer probiotics for prevention of cholera | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $248,600 | February 1, 2020 | January 31, 2023 | LESSER, CAMMIE | reporter.nih.gov |
| Intravacuolar network dense granule protein biology in chronic Toxoplasma infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $246,000 | January 13, 2020 | December 31, 2022 | BZIK, DAVID J | reporter.nih.gov |
| Novel vacuole biology in chronic Toxoplasma infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $246,000 | February 4, 2020 | January 31, 2023 | BZIK, DAVID J | reporter.nih.gov |
| Influence of Diet, Iron Stores, and Toxic Metals on Uptakes and Effects on Uterine Fibroid Risk in African American Women | NIH | National Institute of Nursing Research | 2021 | $245,080 | April 10, 2019 | September 30, 2023 | UPSON, KRISTEN | reporter.nih.gov |
| A Secreted Viral Protein Determines Norovirus Persistence By Immune Evasion | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $244,979 | August 1, 2020 | July 31, 2022 | LEE, SANGHYUN | reporter.nih.gov |
| Disulfiram for Entameoba histolytica Enteric Diarrhea [DEED] Trial | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $243,880 | May 13, 2022 | April 30, 2024 | WARREN, CIRLE ALCANTARA | reporter.nih.gov |
| Developing vaccines against the intracellular and extracellular Lifestages of the Cryptosporidium parasite | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $242,250 | April 25, 2025 | March 31, 2027 | GILCHRIST, CAROL A | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Maryland Baltimore | Baltimore, MD | 11 | $66.8 million | 0 | $0 |
| University of Washington | Seattle, WA | 16 | $27.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 21 | $25.5 million | 0 | $0 |
| Washington University | Saint Louis, MO | 17 | $22.6 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 13 | $20.2 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 9 | $17.2 million | 0 | $0 |
| Yale University | New Haven, CT | 10 | $15 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 10 | $14.9 million | 0 | $0 |
| University of California at Davis | Davis, CA | 20 | $14.6 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 5 | $13.3 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 11 | $13 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 4 | $12.6 million | 0 | $0 |
| University of Florida | Gainesville, FL | 11 | $12.1 million | 0 | $0 |
| Stanford University | Stanford, CA | 13 | $11.1 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 10 | $11.1 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 5 | $10.7 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 12 | $10.1 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 4 | $9.6 million | 0 | $0 |
| Emory University | Atlanta, GA | 10 | $9.4 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 4 | $9.3 million | 0 | $0 |
| University of Calgary | Calgary | 1 | $8.5 million | 0 | $0 |
| Cornell University | Ithaca, NY | 5 | $7.3 million | 0 | $0 |
| University of Rochester | Rochester, NY | 8 | $7.2 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 13 | $7 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 5 | $6.9 million | 0 | $0 |
| University of Illinois at Urbana-Champaign | Urbana, IL | 6 | $6.5 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 8 | $6.3 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 5 | $6.1 million | 0 | $0 |
| Duke University | Durham, NC | 6 | $6.1 million | 0 | $0 |
| Ohio State University | Columbus, OH | 5 | $6.1 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 7 | $5.9 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 3 | $5.8 million | 0 | $0 |
| University of Vermont & ST Agric College | Burlington, VT | 7 | $5.7 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 7 | $5.6 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 7 | $5.6 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 8 | $5.5 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 6 | $5.2 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 3 | $5.2 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 5 | $5.1 million | 0 | $0 |
| Intralytix, Inc. | Columbia, MD | 1 | $4.9 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 4 | $4.7 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 3 | $4.6 million | 0 | $0 |
| Phagepro, Inc. | Mansfield, MA | 4 | $4.5 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 3 | $4.3 million | 0 | $0 |
| Colorado State University | Fort Collins, CO | 2 | $4.2 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 1 | $4.2 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 4 | $4.2 million | 0 | $0 |
| University of Chicago | Chicago, IL | 3 | $3.6 million | 0 | $0 |
| University of New Mexico Health Scis CTR | Albuquerque, NM | 3 | $3.6 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 1 | $3.5 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 4 | $3.5 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 2 | $3.5 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 3 | $3.4 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 3 | $3.3 million | 0 | $0 |
| Indiana University | Bloomington, IN | 4 | $3.3 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 8 | $3.3 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 7 | $3.3 million | 0 | $0 |
| Ascribe Bioscience Inc. | Ithaca, NY | 2 | $3.1 million | 0 | $0 |
| CUNY City College | New York, NY | 1 | $3 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 4 | $3 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 2 | $2.9 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 4 | $2.9 million | 0 | $0 |
| Primetime Life Sciences, LLC | Germantown, MD | 1 | $2.8 million | 0 | $0 |
| Consolidated Safety Services, Inc. | Fairfax, VA | 1 | $2.6 million | 0 | $0 |
| Brown University | Providence, RI | 2 | $2.6 million | 0 | $0 |
| University of California-Santa Cruz | Santa Cruz, CA | 2 | $2.6 million | 0 | $0 |
| Wayne State University | Detroit, MI | 3 | $2.6 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 4 | $2.5 million | 0 | $0 |
| Research Inst of Fox Chase Can CTR | Philadelphia, PA | 1 | $2.5 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 2 | $2.5 million | 0 | $0 |
| Clemson University | Clemson, SC | 4 | $2.5 million | 0 | $0 |
| Godx, Inc. | Madison, WI | 2 | $2.4 million | 0 | $0 |
| National Bureau of Economic Research Inc | Cambridge, MA | 1 | $2.4 million | 0 | $0 |
| Glaxosmithkline Biologicals | Rixensart | 1 | $2.4 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 1 | $2.4 million | 0 | $0 |
| Woods Hole Oceanographic Institution | Woods Hole, MA | 1 | $2.4 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 2 | $2.4 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 6 | $2.4 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 3 | $2.3 million | 0 | $0 |
| University of Louisville | Louisville, KY | 2 | $2.3 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 4 | $2.2 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 2 | $2.2 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 1 | $2.1 million | 0 | $0 |
| University of Mississippi Med CTR | Jackson, MS | 1 | $2.1 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 5 | $2.1 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 4 | $2 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 1 | $2 million | 0 | $0 |
| Luceome Biotechnologies, LLC | Tucson, AZ | 1 | $2 million | 0 | $0 |
| University of South Florida | Tampa, FL | 2 | $1.9 million | 0 | $0 |
| Rise Therapeutics, LLC | Rockville, MD | 1 | $1.9 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 3 | $1.8 million | 0 | $0 |
| Ondavia, Inc. | Hayward, CA | 3 | $1.8 million | 0 | $0 |
| Stemloop, Inc. | Evanston, IL | 2 | $1.8 million | 0 | $0 |
| Tda Research, Inc. | Golden, CO | 2 | $1.8 million | 0 | $0 |
| Worcester Polytechnic Institute | Worcester, MA | 1 | $1.7 million | 0 | $0 |
| Giner, Inc. | Newton, MA | 1 | $1.7 million | 0 | $0 |
| University of Tennessee Health Sci CTR | Memphis, TN | 2 | $1.7 million | 0 | $0 |
| Foundation Instruments, Inc. | Collierville, TN | 2 | $1.7 million | 0 | $0 |
| Texas A&m Agrilife Research | College Station, TX | 3 | $1.7 million | 0 | $0 |
| Oregon State University | Corvallis, OR | 3 | $1.7 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 261 | $145,422,450 | 0 | $0 |
| 2024 | 296 | $138,348,673 | 0 | $0 |
| 2023 | 287 | $132,585,600 | 0 | $0 |
| 2022 | 292 | $135,173,563 | 0 | $0 |
| 2021 | 316 | $154,082,686 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | May 7, 2027 | Not listed | Notice number printed on 2 awards here | |
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 408 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 408 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 408 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 408 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 408 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 408 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 408 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.